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ABSTRACT
STUDY OF THE EFFECTS OF SILVER IONS AND SILVER NANOPARTICLES ON
EMBRYONIC DEVELOPMENT
Martha Sharisha Johnson
Old Dominion University, 2019
Director: Dr. Xiao-Hong Nancy Xu

This dissertation focuses on the study of the toxicity of metal nanoparticles (NPs)
and their ions on the development of zebrafish embryos, aiming to understand unique
biological effects of NPs and ions, and design new in vivo assays to characterize the
toxicity of these metal NPs and metal ions.

Currently, the underlying molecular

mechanisms of biological effects of nanomaterials are partially understood. Some studies
assume that the toxic effects of NPs can be attributed to the release of their ions. We
investigate the effects of silver NPs (Ag NPs) and silver ions (Ag+ ions) on the embryonic
development of zebrafish and compare both of their biocompatibility and toxicity. By
statistically comparing the distributions of normal, deformed, and dead embryos, we
conclude that the Ag+ ions cause deformities and death of developing embryos in a
concentration dependent manner, where the critical concentration of the Ag+ ion is 0.20
µM for chronic exposure and varies in a stage-dependent manner in acute exposures
during specific developmental stages. Exposure to Ag+ ions influences specific types of
defects in development, which are far less drastic than those caused by the purified Ag
NPs with the same amount of Ag atom. Thus, we can conclude that toxicity of Ag NPs
on embryonic development is not due to the release of Ag+ ions, but rather their own
unique physicochemical properties. We also synthesized and purified spherical Ag NPs
(42 nm in diameter) that are stable (non-aggregated) in egg water media. We examined

the biocompatibility and toxicity of single Ag NPs in vivo at specific stages of development
and the defects associated with treatment at those specific developmental stages. We
then developed new imaging approaches to characterize single Ag NPs as they interact
with key brain biomarkers that are significant for neurological development in zebrafish
embryos. More specifically, we exposed Tg(pax2a:GFP) zebrafish embryos to various
concentrations of the Ag NPs, and studied the effects of Ag NPs on the expression of the
pax2a gene during treatment using fluorescent microscopy. Sublethal concentrations of
the Ag NPs (0.00, 0.50, 1.00, 2.00, and 5.00 pM) resulted in a phenotypical dependent
effect on embryonic development. However, we did not observe a significant decrease
in expression of pax2a:GFP when exposing developing embryos to the Ag NPs. We did,
however, observe that a higher dose of the Ag NPs led to severe deformities. We have
further demonstrated the effects of Ag NPs on cardiac response. We found a decrease in
heart-rate of both normal and deformed zebrafish, as the developing embryos were
exposed to the Ag NPs. Our study also shows the dose-dependent effects of Ag NPs on
eye development, where higher concentrations of Ag NPs leads to microphthalmia in
developing embryos. We further studied the accumulation of Ag NPs in treated embryos.
We found that each embryo accumulated a significant amount of Ag NPs in a dose
dependent manner, which explains why some embryos developed normally, abnormally
or resulted in embryonic death during treatment. In summary, this study demonstrates
that developing zebrafish embryos can serve as effective in vivo model organism to study
biocompatibility and toxicity of nanomaterials and metal ions, and can potentially lead to
better design of applications to study developmental biology.
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CHAPTER I
OVERVIEW
Nanomaterials pose unique physicochemical and optical properties that allow realtime observation of cellular uptake and functions in single living cells and other animal
models, like zebrafish embryos.1-3 These unique properties allow for their use in many
interdisciplinary fields, and medical, industrial and commercial applications. However,
there is still limited knowledge about the biocompatibility of these nanomaterials. A better
understanding of their effects on living organisms will enable us to rationally design more
biocompatible nanomaterials for a wide variety of applications. The challenges with
conventional studies and methods currently available are that they are not able to
characterize both dose and physiochemical properties of nanomaterials in vivo and in situ
in real time at the single cellular resolution. Many of these studies use methods that are
used for common chemical techniques to analyze toxicity and biocompatibility. However,
as shown in other studies,1-7 nanomaterials are unlike conventional chemicals because
they are highly heterogeneous and yet single NPs have distinct physiochemical properties
as well as highly dynamic systems that can alter over time. Bioanalytical tools that strive
to analyze these properties further at single cellular resolution is vastly needed and can
tell more prominent information about their capabilities.
Noble metal nanoparticles possess physicochemical properties that are
exceedingly compatible in a wide range of applications, including biomedical engineering
and design.

Silver nanoparticles (Ag NPs) possess a broad range of potential

applications including serving as therapeutic agents and ultrasensitive optical imaging
probes.

5, 6, 8, 9

As Ag NPs have also been used in consumer products, the potential

The journal this dissertation follows is ACS Nano
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release of Ag NPs to aquatic environments could lead to adverse health impacts on
humans.
Ag NPs possess distinct plasmonic optical properties and very high Rayleigh
scattering.

Because Ag NPs resist photobleaching and photoblinking, the optical

properties allow our lab to design Single Nanoparticle Optical Biosensors (SMNOBS) that
distinctively overcomes the optical drawbacks of other fluorescent super-resolution
imaging methods. We have demonstrated that single Ag NPs can serve as superior
photostable optical molecular probes and sensors for imaging of single biomarker
molecules, probing ligand-receptor interactions in real time, and imaging single live cells
and embryos in real time, using dark-field optical microscopy and spectroscopy (DFOMS).
5

Previous studies from our group have explored in depth how nanotoxicity can
contribute to malformations and abnormalities in embryonic development. We have
designed ultrasensitive in vivo bioanalytical imaging tools to address the questions of
toxicity and biocompatibility of nanoparticles in living systems by using zebrafish embryos
as our in vivo animal model. Zebrafish (Danio rerio) serves as an excellent model
organism to study human development and physiology, human diseases, and toxicity
screening for many potential drugs. They have many distinct advantages over other in
vivo models like mice and rats. Zebrafish embryos have a rapid developmental process
where they will complete embryogenesis within 120 hours post fertilization (hpf). This is
faster than most animal models used in other studies.

During their development,

zebrafish embryos are transparent. This enables real-time monitoring and studying the
effects and transport of single NPs. This also allows for direct imaging of molecular

3

changes and abnormalities during embryogenesis. Because zebrafish has a genetic
makeup that is similar to humans, zebrafish have been used in many screenings for
therapeutic agents and toxicity studies of many conventional chemicals and drugs.

10-16

Transgenic zebrafish are highly used as the go-to in vivo animal model for the exploration
of the molecular development and for the design of newer imaging tools used in many
labs.

17-19

Using these transgenic models has allowed many researchers to essentially

study biomarkers that were otherwise impossible to research in vivo.
In developmental biology, embryonic development is still not fully understood, but
with the help of transgenic zebrafish in vivo models, much has been accomplished within
the last decade, which has contributed to improving the design of transgenic models to
study mechanisms regulated by embryogenesis.

The biological functions that are

enabled during embryogenesis are highly regulated and complex processes that involve
many different macromolecules that are still being identified. Our lab is particularly
interested in neurological development because this is the central control center of living
systems. Neurological development has many dynamic processes that still puzzle the
neuroscience and developmental biology community. Understanding how the developing
brain and all of its components are regulated and function will aid in establishing better
molecular assays to further explore these and similar questions, leading to the increase
of knowledge in the field of neuroscience.
For this dissertation, we explored in vivo assays and applications to study silver
nanoparticles (Ag NPs) and silver ions (Ag+ ions) upon their effect on embryonic
development, and also the molecular mechanism of embryonic neurological development
and how nanomaterials can influence and alter this development over time. Each study

4

discussed will highlight a significant bioanalytical design that will allow further exploration
into key developmental stages that can contribute to the understanding of biomedical
applications using nanomaterials. This dissertation includes six chapters. In Chapter I,
we provide a brief overview of the research background, the significance of this
dissertation research, and outline the contents of each chapter.
In Chapter II, we describe the design of standard in vivo toxicological assays that
are efficient, easy to use, and affordable to screen the toxicity of silver cations during
embryogenesis, as illustrated in Figure 1.

To this end, we have demonstrated an

ultrasensitive method to study the toxicity of Ag+ ions on zebrafish embryos aiming to
assess nanotoxicity on embryonic development, heart functions, and hatched time. Dosedependent toxic effects of the Ag+ ions on embryonic development were observed,
showing that the number of zebrafish developed normally decreased while the number of
dead zebrafish increased as Ag+ ion concentrations increased. The Ag+ ions not only
interfere with embryonic development but also heart development and functions. We
observed heart deformities and lower heart rates in zebrafish exposed to Ag + ions.
Studies are needed for a more in-depth mechanistic understanding of Ag+ ion induced
heart deformities. Moreover, delays in hatching mechanisms of treated zebrafish were
observed in a dose-dependent manner. Zebrafish embryos exposed to high
concentrations of Ag+ ions hatched later.
In Chapter III, we investigated the effects of silver cations to determine their effects
on various developmental stages and their related mechanisms as illustrated in Figure 2.
To this end, we incubated the embryos with Ag+ ions for two hours and characterized their
effects upon embryonic development over time using a wide variety of bioanalytical tools.

5

We found that the effects of silver cations on embryonic development highly depended
upon embryonic developmental stage and incubation time. We also saw concentration
and stage dependent effects of Ag+ ions on hatching rate and cardiac response. The
results demonstrated the need for future investigation of heavy metal toxicity exploring
key developmental stages.
In Chapter IV, we continued our in vivo assay design to explore the biocompatibility
and toxicity of 41.5 nm Ag NPs in zebrafish embryos at key developmental stages, as
illustrated in Figure 3.

To determine the specific effects of Ag NPs on various

developmental stages and their related mechanisms, we incubated the embryos with Ag
NPs for two hours and characterized their effects upon embryonic development over time
using similar bioanalytical tools described in chapter II and chapter III. We found that
the effects of NPs on embryonic development highly depended upon the embryonic
developmental stage, incubation time, the size and dose of NPs.
In Chapter V, we used our in vivo model to investigate the mechanisms of effects of
purified and well-characterized nanoparticles (NPs) on embryonic developments,
specifically neurological development. To that end, we selected a vital protein biomarker
that plays an important role in neurological development, used transgenic embryos that
express the protein biomarker fused with fluorescence proteins as model organisms, and
studied the effects of NPs on their functions using fluorescence microscopy and
plasmonic spectroscopy.
In Chapter VI, we summarized our research findings described in the preceding
chapters, pointed out the primary contributions of these original research activities, and
emphasized the possible future research directions.

6

Figure 1: Schematic illustration of in vivo study of chronic treatment of silver
cations on embryonic development.

7

Figure 2: Illustration of probing of stage-dependent toxicity of AgNO3 using
zebrafish embryos.

8

Figure 3: Illustration of using 43 nm, Ag NPs to study the biocompatibility and
toxicity in living zebrafish embryos in real-time at specific developmental stages.

9

Figure 4: Illustration of using 43 nm single Ag NPs to study the toxicological effects
on neurological development in zebrafish embryos in real-time.
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CHAPTER II
IN VIVO STUDY OF CHRONIC TREATMENT OF SILVER CATIONS ON EMBRYONIC
DEVELOPMENT
INTRODUCTION
Heavy metals have been widely used in multiple fields from domestic and
industrial, to medical and technological applications. With this wide distribution of use
across many fields, their potential impact on both environmental and biological health has
been well studied over the years.

Understanding the impact requires studies to

understand the mechanisms of exposure and toxicity. Some toxicological studies of some
heavy metals, such as cadmium and mercury have shown that heavy metals and their
ions can lead to genetic mutations and functional decrease in biological systems.

20-23

Other studies have shown a loss of enzyme stability and an increase of apoptotic
biomarkers in vitro when exposed to heavy metals such as titanium and zinc. 24, 25 These
studies have allowed for modifications to be made when utilizing heavy metals in research
and applications. Although many strides have been made to understand the toxicity of
heavy metals, a better approach and application is needed to address early
developmental adversities from heavy metal exposure.
Silver metal has been used throughout the decades for its unique properties.
Silver ions (Ag+ ions) and their toxicological exposure have been of great concern with a
very significant increase of silver being used in nanotechnology.

26-31

This increase is in

response to silver’s antimicrobial and antibacterial properties. Silver nanomaterial has
shown increasing use in consumer products (such as clothing and home appliances) as
well as in biomedical applications (such as biosensors and imaging probes). Although
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increasingly used in biomedical applications, understanding the biocompatibility of silver
nanomaterial is essential for their success in clinical applications. Our studies have shown
a toxicology concentration and stage dependent effect of Ag nanoparticles on embryonic
development.
Many suggest that the toxicity of Ag NPs is reflected in the ionic properties of silver.
Some attribute the toxicity of Ag NPs to the dissolution of Ag ion, without a direct link of
the ionic relationship with NP toxicity. In order for us to understand nanoparticle toxicity
to rationally design more biocompatible nanoparticles, we must understand the
mechanism of toxicity of the nanomaterial, thus we can rationally design more
biocompatible applications.
Zebrafish (Danio rerio) have been extensively used as an in vivo model for
embryological development because of its small size, its short breeding cycle, and the
wealth of information available for manipulation. The zebrafish is transparent throughout
development, allowing for surveillance of development from outside the chorion without
disturbing its developmental process. Zebrafish can spawn in large numbers from week
to week, producing large masses of fertilized eggs, which are ideal for observing different
developmental stages. The embryonic development is so fast and efficient that primary
organ development is completed within the first 48 hours post fertilization (hpf), and the
normal embryo will hatch and swim by 72 hpf. Since zebrafish are so genetically similar
to other organisms and even humans, zebrafish have been widely used for chemical and
drug analysis and screening. Our group was the first to use the zebrafish to study the
toxicity of nanomaterials. Therefore, zebrafish embryos offer a unique opportunity to

12

investigate developmental processes upon treatment with heavy metals to determine the
adverse effects during development.
Here, we investigate the roles of Ag+ ions on embryonic development in
comparison to our previous studied silver nanoparticles. Here, zebrafish embryos were
chronically exposed to silver nitrate in corresponding concentrations that corresponded
to the published toxicological concentrations of our Ag NPs studies. Phenotypic and
survivability observations can be compared to other toxicological studies. Heartbeat
analysis was also studied to show the effects of ionic concentrations on cardiac function.
Analysis was also carried out on embryo hatching mechanisms from treatment with Ag+
ions.
RESULTS AND DISCUSSION
Early-developing embryos as in vivo model organisms and assays
Zebrafish embryos have recently gained interest as being an optimal animal model for
toxicity and genetic studies. Zebrafish has several unique properties that allow them to
be a well-defined animal model.

Optical images in Figure 5 A-B show normal

developmental zebrafish embryos at cleavage (0.75-2.25 hours-post-fertilization, hpf),
germ ring stage (8-10 hpf), late segmentation (24 hpf), hatching (48 hpf), hatched embryo
(72 hpf), and fully developed larvae (120 hpf). Fast embryogenesis allows rapid multiple
studies to be performed in a shorter amount of time than using other animal models that
take longer to develop.

Because zebrafish are optically transparent during

embryogenesis, which is a characteristic of using zebrafish embryos, monitoring of
cellular division and migration as well as the development of primary and secondary
organs can be observed and characterized. This allows for real-time monitoring and
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analysis of the effects of toxins on development can be observed during the experiment.
Furthermore, a large number of embryos can be generated rapidly (overnight) at very low
cost, serving as high-throughput in vivo assays to screen biocompatibility and toxicity of
many toxins and materials. Zebrafish have gained a lot of focus from genetic and
developmental biologists because of the similarity with humans in genetic makeup.
Behavioral studies using Zebrafish have led to many breakthroughs in neurological
development allowing scientists to explore mutated genes and disarrayed pathways that
have been found to occur in early stages of neurological abnormalities.
Using embryos in vivo in studies have numerous advantages over in vitro cultured
cells for the study of biocompatibility and toxicity of metal ions. For instance, in vivo assay
enables one to investigate the effects of heavy metals upon different development stages
of cells while studying multiple others all in one organism. Thus, the selection of zebrafish
embryos as our animal model to study the toxicity of silver ions was our preference.
Study of concentration-dependent toxicity of Ag+ on embryonic development
To study the concentration dependent toxicity of our silver ions, we incubated
cleavage-stage embryos (2-4 hpf) with a series of concentrations of AgNO3 (0-1.20 µM)
that was suspended in egg water for 120 hours (h).

Representative embryonic

developmental stages were imaged and assayed every 24 h over 120 hpf until the
embryos fully developed (Figure 6A). We determined and characterized the number of
embryos that developed to normal zebrafish (Figure 5A), died (Figure 6B), or developed
into deformed zebrafish (Figure 5A). The results in Figure 6 show various degrees of
dependence on embryonic development upon the concentrations of AgNO 3. As the ion
concentration increased from 0 to 1.20 µM, the number of embryos that developed to

14

Figure 5. Optical images of zebrafish embryos.
(A) Cleavage stage embryo (0.75-2.25 hpf) incubated with AgNO3 (0.00-1.20 µM) over
120 h at 28.5oC. (B) Normally developing embryos: (a) germ-ring stage (8-10 hpf); (c)
late segmentation stage (24 hpf); (d) hatching stage (48 hpf); (d) protruding mouth
pharyngula stage (72 hpf); and (e) fully developed larvae (120 hpf) lateral view. (C) Dead
embryos. (D) Abnormally developed embryos at 120 hpf showing (a-b) finfold
abnormality; (c-d) tail/spinal cord flexure and truncation; (e-g) pericardial sac edema and
yolk sac edema; and (h) eye and head abnormities. Many of the deformed zebrafish had
multiply types of deformities. Scale bar for (A -C) = 200 µM; Scale bar for (D) = 250 µm.
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normal zebrafish decreased, while the number of embryos that became dead or
developed to the deformed zebrafish increased, given way to a concentration
dependency of AgNO3.
High concentrations of the silver ion generated several common and severe
deformed zebrafish (Figure 5D) observed starting at 48 hpf in the embryos exposed to
0.2-0.8 µM AgNO3, which included: (a-b) finfold abnormality; (c-d) tail/spinal cord flexure
and truncation; (e-g) pericardial sac edema and yolk sac edema; and (h) eye and head
abnormities. The distributions of types of deformities versus the Ag ion concentrations in
Figure 7 show that more embryos develop to severely deformed zebrafish (e.g., cardiac
malformations and head abnormalities) in the 0.3 and 0.4 µM AgNO 3.
Interestingly enough, the most severe deformities that showed multiple
abnormalities were observed in the 0.4 and 0.8 µM concentrations. Taken altogether,
these interesting findings show definite concentration dependent toxic effects of Ag ion
upon embryonic development. This is interesting, considering EPA guidelines for Silver
Acute toxicity falls within the toxicity range of 2-3 µg/L silver ion.

32

Table 1 shows

representative images of deformities for each concentration treatment group. These
deformities were scored from 1 being the least severe in abnormality and 4 being the
most severe in abnormality. As we can see, the more severe deformed zebrafish were
captured in the 0.3 – 1.2 µM, where head abnormalities and eye abnormalities were
prevalent. We did observe that the more severe zebrafish with these abnormalities also
had multiple other deformities like pericardial sac edema and yolk sac edema.

16

Figure 6: Biocompatibility and toxicity of Ag+ Ions show dependency on its
concentration.
Histogram of distribution of normally developed (green), dead (red), and deformed (blue)
zebrafish versus concentration of the Ag+ ion for (A) 4 hpf; (B) 24 hpf; (C) 48 hpf; (D) 72
hpf; (E) 96 hpf; and (F) 120 hpf. The means and standard deviations (error bars) of the
total number of embryos that developed normal and deformed, or became dead shown
for each given concentration are from triplicate measurements.
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Since toxicity of metal ion nanomaterials has been cited to be caused by the
leaching or exposure to the metal ion, we decided to evaluate the overall toxicity Silver
Nanoparticles to our toxicity levels in this study.33-38 We found that the abnormalities
observed from the exposure of the Ag+ ions (finfold abnormality, tail flexure, yolk sac
edema, pericardial sac edema, and eye and head abnormalities) where all similar to those
exposed to Ag NPs. 33, 35, 37, 38 This suggests that the toxicity biological mechanisms that
are involved in the formation of these abnormal developments (i.e. molecular biomarkers
and genetic pathways) are similar between Ag+ and Ag NPs, which are still not well
understood. However, the lethal level of toxicity in Ag NPs was found to be much lower
when converted to Ag+ molarity concentrations for comparisons, where concentrations
was in the nanomolar range. Thus, challenging the theory that the toxicity of metal and
metal oxide nanoparticles, or in this case Ag NPs, is related to the release of the Ag+ ion.
Study of effects of Ag+ on hatching of embryos
Zebrafish embryos will hatch out of their chorions after organogenesis for
survivability.

The longer the embryo stays inside the chorion may lead to the embryo

being more susceptible to predators or abnormal growth. 39 During natural hatching, the
chorion is digested from the inner surface, and tail movements of the embryo help to
break the remaining chorion. This hatching usually happens between 48-72 hpf. Many
studies have reported the delay in hatching after exposure to different toxins.

28, 30, 36, 40

Mechanisms of this delay, although not widely understood, has been theorized to be
because of the hardening of the outer layer of the chorion, making it difficult for the embryo
to break free. Effects of Ag+ ions on this hatching process has not been widely studied in
zebrafish.
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Figure 7: Deformities of Zebrafish resulted from being treated chronically by
AgNO3.
Histograms of the percentages of Zebrafish with five representative types of deformities
versus concentration of Ag+ ions; (a) finfold; (b) tail flexure; (c) yolk sac edema; (d) eye
abnormality; (e) head abnormality; and (f) pericardial sac edema.

The means and

standard deviations (error bars) of the total number of embryos that developed each type
of deform shown for each given concentration are from triplicate measurements.
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Number of Zfish with
Severity Scale
C
(µM)

1

2

3

4

Number of
Dead
Embryos

Images of Zebrafish

0

Normal Development

74 ±1.8

2 ±0.5

Normal Development

74±1.8

2±0.5

0

0.05

Pericardia Sac Edema, Finfiold Abnormities 73±1.8

1

3±0.8

0.2 Pericardia Sac Edema, Finfiold Abnormities 46±3.4

1

1

2

24+3.4

0.1

Head and Eye Abnormities, Yolk Sac
Edema, Pericardial Sac Edema, Tail
Flexures

17±1.0

4

3

4

9

34±1.5

Head and Eye Abnormities, Yolk Sac
Edema, Pericardial Sac Edema

9±1.5

3

6

2

9

52±2.1

0.3

0.4
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Head and Eye Abnormities, Yolk Sac
Edema, Pericardial Sac Edema

0±0

7

68±1.0

Head and Eye Abnormities, Yolk Sac
Edema, Pericardial Sac Edema

0±0

2

70±2.0

0.8

1.2

Table 1: Summary of Dependence of Number of Normal and Deformed Zebrafish
upon concentration of AgNO3.
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To study hatching, observations were made every 2 hours to identify what hpf the
embryo hatched from the chorion. Figure 8 shows that as the concentration of Silver
nitrate increase, embryo hatching time was decreased. The controls hatched out of
chorions around 50-60 hpf. Lower concentrations, 0.05-0.1µM, also showed a normal
rate in hatching time. However, the higher concentrations, 0.20-0.80 µM, µM showed a
hatching rate up until 96 hpf.

This delay in hatching does show a concentration

dependency. We also noticed that deformed zebrafish hatched out at a later rate than
those zebrafish that developed normally. These deformed zebrafish could potentially be
delayed in hatching because of a lack of physical abilities to move, as well as a delay in
chemical release of hatching enzymes. Further genetically studies could be used to
reflect these enzyme levels during hatching.
Quantitative study of effects of Ag+ on heart rate of developing embryos
Heartbeat analysis was taken at 24, 48, and 120 hpf by visually counting of the
beats per minute and compared between concentrations, as well as normal or abnormal
development Figure 9A shows the quantitative results of those zebrafish that were
normally developed at each time point. Heart rates show a decreasing effect as the
treatment concentration increases, with a significant decrease at 48 and 120 hpf for the
0.4 µM treated zebrafish. Figure 9B shows the quantitative results of those zebrafish that
were abnormally developed at each time point. There is a significant decrease, again,
with the higher concentration (0.8 µM) compared to the other two concentrations. These
results do, in fact, reflect that higher silver ion concentrations have an effect on cardiac
function.
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We observed a significant difference in heart rate between normal development
and deformed zebrafish at those treated ion concentrations that had both normal and
deformed zebrafish. This demonstrated an adverse effect on cardiac development in
embryos treated with silver nitrate.
Study of accumulation of Ag+ ions in developing embryos
Treatment solution from each individual zebrafish larvae was analyzed before and
after the treatment of the ion using GF-AAS. Figure 10 shows the amount of Ag+ that was
accumulated in the individual normal larvae (a), deformed larvae (c), and those embryos
that were dead (e) by the end of the 120 hr treatment plotted over at the different
concentrations. The averages of those normal (b), deformed (d), and dead (f) embryos
are also shown in the plots. From the results, we show that the amount of Ag + found in
the 0.4-1.2 µM abnormally developed larvae was not significantly different from those that
were dead by the end of the treatment in the same concentrations. However, we do see
a significant difference in the 0.4 and 0.8 µM treated larvae that developed normally
compared to the deformed and dead larvae. The accumulation rate is much longer at the
end of exposure for those larvae that developed normally. This could suggest that the
zebrafish that developed normally were able to extrude the Ag+ from its system, allowing
it to function normally under heavy metal exposure, compared to those who either died
during exposure or developed abnormally.
SUMMARY
In conclusion, we have demonstrated an ultrasensitive method to study the toxicity
of Ag+ ions on zebrafish embryos aiming to assess nanotoxicity on embryonic
development, heart functions, and hatched time. Dose-dependent toxicity effects of the
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Ag+ ions on embryonic development were observed, showing that the numbers of
zebrafish developed normally decreased while the numbers of dead zebrafish increased
as Ag+ ion concentrations increased. The Ag+ ions not only interfere with embryonic
development but also heart development and functions. We observed heart deformities
and lower heart rates in zebrafish exposed to Ag+ ions. Further studies are needed for a
deeper understanding of how Ag+ ions cause heart deformities from a mechanistic
perspective. Moreover, delays hatching in zebrafish were observed in a dose-dependent
manner. Zebrafish embryos exposed to high concentrations of Ag+ ions hatched later.
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Figure 8: Study of hatching rate of zebrafish treated chronically by AgNO3.
Histogram of the percentages of Zebrafish that successfully hatched during the exposure
to the Ag+. Newly hatched embryos were observed every 5 hours during incubation and
recorded at (a) 56 hpf in black; (b) 66 hpf in pink; (c) 76 hpf in cyan; (d) 86 hpf in purple;
and (e) 96 hpf in orange.

The means and standard deviations (error bars) of the

percentage of total number of embryos that hatched at given time points shown for each
given concentration are from triplicate measurements.
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Figure 9: Study of heart rates of zebrafish treated chronically by AgNO3.
(A) Plotted graph of the average heart rate and standard deviation (error bars) of normally
developed Zebrafish exposed to the Ag+. Heart Rates were recorded at (a) 24 hpf in blue;
(b) 48 hpf in orange; and (c) 120 hpf in green. Total number of zebrafish counted during
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the study represented at each time point as (d) 24 hpf as blue bar; (e) 48 hpf as orange
bar; and (f) 120 hpf as green bar. (B) Plotted graph of the average heart rate and standard
deviation (error bars) abnormally developed Zebrafish exposed to the Ag+. Heart Rates
were recorded at (a) 24 hpf in blue; (b) 48 hpf in orange; and (c) 120 hpf in green. Total
number of zebrafish counted during the study represented at each time point as (d) 24
hpf as blue bar; (e) 48 hpf as orange bar; and (f) 120 hpf as green bar.

27

Figure 10: Study of Ag+ ion uptake in zebrafish treated chronically by AgNO3 since
their cleavage stage shows concentration dependency.
Histogram of the number of micromoles (µmole) of Ag+ that was uptake by the embryo
during treatment. Treatment solution was collected before and after ion exposure and
analyzed using GFAAS. The recovered ionic moles was plotted against the concentration
of the treatment solution for each (A) Normal developed larvae with (a) green circle being
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individual normal larvae and (b) green triangle being the average of the individual normal
larvae; (B) Abnormally developed larvae with (c) blue circle being individual deformed
larvae and (d) blue triangle being the average of the individual deform larvae; or (C) dead
embryos with (e) red circle being individual dead embryos and (f) red triangle being the
average of the individual dead embryos, to represent the zebrafish embryo at 120 hpf
after treatment.
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MATERIALS AND METHODS
Reagents and supplies
Deionized (Di) water (18 MΩ, Barnstead) was used to prepare all solutions. AgNO 3
was purchased from Sigma and stored in small premeasured aliquots in small amber
bottles until treatment solution preparation.
Breeding and monitoring of zebrafish embryos
Wild type adult zebrafish (Aquatic Habitats) were raised and maintained as
previously described.

41-44

A 4:3 (female: male) ratio of breedable adult zebrafish were

set up the night before the experiment in a 10.0 L clear housing tank (Pentair Aquatic
Habitats) for mating using fresh circulated system water maintained at 28.5°C. Once the
light was on the next morning (14 h light: 9 h dark circadian cycle), adults were allowed
to chase and breed until a sufficient amount of embryos were present. Healthy fertilized
embryos were collected into fresh system water using a siphoning collection hose. Once
collected, healthy embryos were transferred into a petri dish containing egg water (1.0
mM NaCl) and washed three times with egg water to remove the surrounding debris. All
experiments involving embryos and zebrafish were conducted in compliance with IACUC
guidelines (protocol # 15-012).
Study of concentration-dependent toxicity of Ag+ on embryonic development
Once embryos reached cleavage stage (2 hpf), embryos were treated in egg water
and incubated with a dilution series of AgNO3 (0.00, 0.05, 0.10, 0.20, 0.30, 0.40, 0.80,
and 1.20 µM) in 24-well plates for 120 h, one embryo per well. The treated embryos were
incubated in a water bath at 28.5 °C for 120 h for which no light was provided to prevent
photodecomposition of the Ag+ ion. The developing zebrafish embryos were imaged over
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time at 0, 24, 48, 72, 96, and 120 hpf by bright field optical microscopy using an inverted
microscope (Zeiss Axiovert) equipped with a CCD camera (Coolsnap, Roper Scientific)
and a color camcorder (Sony). Twelve embryos were studied for each concentration in
one run of the experiment and three replicates of the runs were used, bringing the total
number of 36 embryos studied for each concentration.
Study of hatching rate of zebrafish upon Ag+ concentrations
When the embryos developed to the hatching stage of developed (48 hpf), we
monitored the embryos every 2 hours for any newly hatched from the embryonic barrier
of the chorions. Newly hatched embryos were imaged for any abnormities. Hatching rate
was then determined each concentration by counting the number of newly hatched
embryos at each given time point and graphed over time.
Quantitative study of heart-beat of developing zebrafish upon Ag+ concentrations
Both treated and control embryos were analyzed for heart rates. Embryos were
recorded using the Sony camcorder and Coolsnap Ez (Roper Scientific) using 100 frames
with a 50 ms interval delay. The recordings were taken at 24, 48, and 120 hpf. The
movies were then converted and analyzed for manual counting of the hearts contractions.
The heartbeat per minute was then compared graphically to both the normal and
abnormal developed fish at each concentration.
Study of the accumulation of Ag+ in zebrafish embryos using GF-AAS
A series of dilutions of standard solutions of Ag+ was prepared using Silver
spectrometric standards (100 ppm) for calibration purposes. Treatment solution from
each individual zebrafish embryo was pipetted out at the beginning and end of the
treatment into 2 mL centrifuge tube. Samples were briefly centrifuged to remove any
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embryo debris. Each solution was analyzed using GF-AAS (Shimadzu Atomic Absorption
Spectrophotometer AA-7000 Series). Calculations were made to determine the uptake
of the ion by the embryo by subtracting the initial silver ion concentrations from the final
silver ion concentrations. The final delta concentration, ΔC, was then plotted over the
treated concentrations.
Data analysis and statistics
Each experiment related to this study was performed at least four times and a total
of 70-75 embryos for each experiment were studied to gain sufficient data for statistical
analysis, permitting the study of the effect of AgNO3 on a bulk amount of embryos at the
single embryo level. We presented averaged the number of normally developed, dead
and deformed zebrafish vs. Ag+ concentration with standard deviations.

We used

conventional statistical analysis methods (t-test, ANOVA, Tukey’s, SigmaStat 3.5 with P
= 0.05) to determine the significance of the different observations between all
concentrations for development, hatching, heartrate and uptake results. A Pairwise Ttest comparison was performed of Deformities Histogram.
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CHAPTER III
IN VIVO STUDY OF THE ACUTE TOXICITY OF SILVER IONS ON EARLY
DEVELOPMENT OF ZEBRAFISH EMBRYOS
INTRODUCTION
Nanomaterials exhibit distinctive physicochemical properties leading to their
unique functions and a wide range of potential applications in engineering, medicine, and
electronics. For example, their surface areas allow effective surface modification for more
effective and more specific in order to increase drug efficacy. Silver nanoparticles (Ag
NPs) have also been increasingly used in consumer products such as socks, home
appliances, and disinfectants.45-53 The potential release of NPs into aquatic environments
could have an adverse impact on human health.54 Thus many studies have indicated
toxicity of nanomaterials including Ag NPs in living organisms. For example, trace
concentrations of Ag NPs result in death and deformities in zebrafish. In the environment,
some types of nano-metals will gradually dissolve by dissolution of metal ions from the
surface of the particle. In addition to nanomaterial toxicity, Ag+ ions could possibly lead to
adverse environmental impacts as Ag+ ions have been utilized as salt precursors in Ag
NP synthesis. Ag+ ions have been reported to interact with thiol groups which are found
in antioxidant resulting in oxidative stress.32 Moreover, metal ions including Ag+ ions can
also inhibit the bronchial Na+/K+-ATPase. Ag+ ions causing osmoregulatory failure in fish.
For example, low concentrations of Ag+ ion as low as 1.7 ng mL-1 resulted in a reduction
in the Na+, K+-ATPase activity in rainbow trout (Oncorhynchus mykiss) gill.

55

Zebrafish (Danio rerio) embryos can serve as an important model organism to
study aquatic environmental toxicity because of numerous advantages, including (i) the
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rapid embryonic development (within 120 h) with well-defined developmental stages ex
utero, which facilitates experimental manipulation and allows the direct observation
organogenesis in vivo; (ii) massive amounts of zebrafish embryos can generate at once
providing high throughput screening animals to analyze; (iii) the organization of the
genome and the genetic pathways controlling signal transduction and development are
highly conserved between zebrafish and human.
Zebrafish are time efficient for care and maintenance and they effortlessly spawn
in large numbers from week to week producing macroscopic fertilized eggs, which are
ideal for observing different developmental stages.56-60 The embryonic development is
so rapid that the first stages of development are completed in the first 24 hours post
fertilization (hpf) and the normal embryo will hatch and swim by 72 hpf. The majority of
developmental mutations identified in zebrafish have close counterparts in other
vertebrates, suggesting that this system can be effectively used as a model for
understanding the developmental processes of higher organisms, including humans. 40, 6163

Despite superior intrinsic properties of zebrafish embryos, they have not yet been
widely used as a standard in vivo assays for screening of biocompatibility and toxicity of
nanomaterials and metal ions at specific developmental stages. Our lab was one of the
first groups to utilize this model to study size-dependent and stage-dependent
biocompatibility on smaller size Ag NPs using this animal model.

64
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RESULTS AND DISCUSSION
Study of effects of Ag+ on different developing stage of embryos
The normal course of embryonic development in zebrafish in the absence
of Ag+ ions for each acute treatment stage is depicted in Figure 11. Acute treatment
occurred at five different stages of development for a 2 hour incubation time with silver
ions: stage I, cleavage stage (2-4 hpf) (Figure 11 A (a)), stage II, gastrula stage (6-8 hpf)
(Figure 11 A (b)), stage III, early segmentation stage (12-14 hpf) (Figure 11 A (c)), stage
IV, late segmentation stage (21-23 hpf) (Figure 11 A (d)) and stage V, hatching period
(48-50 hpf) (Figure 11 A (e)). During stage I, the embryo will undergo dramatic changes
like rapid cellular division and meticulous embryonic pattern formation.51, 65, 66 During
stage II, embryos will undergo cell migration, early gastrulation for the establishment of
organ and organ system development.66-69 Stage III and stage IV is the segmentation
stages. In stage III, embryos will begin somitogenesis and notochord formation, which is
important for proper development of the axial skeleton, the vertebrate spinal column, and
skeletal muscle.69-72

During stage IV, embryos will undergo cardiovascular and

circulatory development where the first embryonic heartbeat and pumping can be
observed.62, 69 Stage V is the hatching stage, where the primary organs of the embryo
would have underwent development, and the embryo will hatch out of its protected
chorion to finish its development. Their developmental stages were selected because of
their importance during embryogenesis.

Changing the embryonic environment and

exposure of toxins and chemicals during these stages have been known to influence
embryos phenotypical development and survivability. These development stages are
proven to be the most sensitive to exposure. 62, 63

35

Embryos at each stage were observed throughout development after acute
treatment with Ag+ ions. Stage I-IV embryos were observed after acute treatment at 24
hpf (Figure 11 B (a)), 48 hpf (Figure 11 B (b)), 72 hpf (Figure 11 B (c)), 96 hpf (Figure 11
B (d)), and 120 hpf (Figure 11 B (e)). Stage V embryos were only observed after acute
treatment at 72 hpf through 120 hpf, (Figure 11 B (c-e)).
Concentration and development stage dependent toxicity study
Danio rerio embryos exposed to sublethal concentrations of Ag+ ions acutely at
selected stages revealed that Ag+ ions induced death, as well as variations in the severity
of morphological defects, increasing with increasing concentrations of the Ag+ ion. Figure
12 shows the overall status of controls and treated embryos at 120 hpf for each Acute
Stage. Stage I is shown in Figure 12A, stage II is shown in Figure 12B, stage III is shown
in Figure 12C, stage IV is shown in Figure 12D, and stage V is shown in Figure 12E. The
critical concentrations for each stage are shown in Table 1. Here, we define the critical
concentration of the Ag+ ions at which only 50% of embryos develop normally.
Stage I resulted in an increasing number of deformities in Ag+ treated embryos as
the concentration increased (Figure 12A), with a critical concentration of least than 0.1
µM. Even after exposure to the lower concentration of silver ions, stage one treatment
resulted in abnormalities. With increasing concentration, there was also an increasing
number of embryonic deaths. At the two highest tested concentrations, a majority of
embryonic death was observed.

Because this stage is prominent for rapid cellular

division, exposure of Ag+ ions at this stage can significantly influence the development of
embryos long term. Thus we see a significantly lower critical concentration at 0.1µM,
which is the lowest for all five treatment stages.
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Embryos treated in stage II had an increasing rate of embryonic death observed in
higher concentrations. Formation of deformities were also observed amongst the lowest
treated Ag+ ion concentration. Critical concentration for stage II was observed at 0.2 µM.
Stage II appeared to display an ample amount of abnormal development amongst all
treatment groups when compared to all other stages. The highest number of deformed
embryos were observed in stage II. As the concentration of Ag+ ion also increased, there
was a decrease in normally developed embryos, and correspondingly, an increased in
embryonic death. The highest concentration treated resulted in complete elimination of
normally developed embryos, with only abnormal or death displaying.

The early

gastrulation stage is significant because at this stage, cellular movement is observed,
where cells start to migrate into positions that will determine their cellular fate.
Stage III shows that embryo treated at this time point did not have drastic
embryonic death until the two highest treated concentration (Figure 11 a). At those
concentrations, there was a majority of embryonic death amongst treated embryos. This
stage presented the lowest amount of abnormally developed embryos from all treatment
groups. The critical concentration was determined to be between 0.40 – 0.80 µM. Stage
III is the early segmentation stage where the notochord and spinal cord are heavily
influenced.
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Figure 11: Normally developed zebrafish at stages I – V at the time of acute
treatment and observations after acute treatment.
(A) Representative optical images of normally developed zebrafish at the time of acute
treatment for stage I – V, (a) 2 hpf (cleavage stage); (b) 6 hpf (early gastrula stage); (c)
12 hpf (early segmentation stage); (d) 21 hpf (late segmentation stage) and (e) 48 hpf
(hatching stage). (B) Representative optical images of normally developed zebrafish
observations after acute treatment for stages I – IV, (a) 24 hpf (late segmentation stage);
(b) 48 hpf (hatching stage); (c) 72 hpf (pharyngula stage); (d) 96 hpf larvae and (e) 120
hpf fully developed larvae. Note that observations for stage V began at (c-e). Scale bar
= 250 µm.
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Stage V was the least sensitive to toxic treatment stage out of all acute
stages. At this stage, there were a significant number of embryos which were not affected
by the Ag+ ion treatment. There was abnormal development in each treatment group, but
the toxic effects of the ion were slightly less than the other concentrations. The most
embryonic death was at the highest treatment concentration, where at least 50% of the
embryos did not survive. The critical concentration was 0.80 µM. This stage also showed
the most amount of embryonic survivalist between all stages. At this stage, the embryo
will start hatching out of their chorions, because of the primary organ development. These
results show the embryo is less affected by the exposure of the silver ion at this stage.
From our previous studies, we were able to compare the toxicity effects of Ag + to
our Ag NPs studies. These results show that the toxicity of single Ag NPs, at different
sizes, have a more toxic effect acutely than their bulk counterparts.
We treated stage I through V embryos acutely with increasing concentrations of
Ag+ ions (0.00 – 1.20 µM). Embryos were carefully monitored post-treatment at 24, 48,
72, 96, and 120 hpf (Figure 11). We examined the abnormalities in developing embryos
at each treated stage. Many morphological defects were observed in the developing
embryo, which included abnormal finfold and tail development, cardiac malformation, yolk
sac edema, and head and eye abnormalities, as recorded in Figure 13.
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Figure 12: Study of concentration and stage dependent toxic effects of AgNO3 on
embryonic developments.
Histograms show the average number of staged embryos (A-E; stages I – V), incubated
with given concentrations of AgNO3 for 2 h, that developed into normal or deformed
zebrafish or died in egg water over 120 hpf. The means and standard deviations (error
bars) of the number of embryos shown for each given concentration are from triplicate
measurements.
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Table 2: Critical Ag+ ion Concentration for Specific Developmental Stages of
Zebrafish.
Stage

I

II

III

IV

V

Critical Concentrations (µM)

>0.1 µM

0.2 µM

0.4-0.8 µM

0.8 µM

0.8 µM

All stages presented some abnormal developing embryos. The shared common
type of abnormality amongst all stages was finfold abnormalities, which typically affects
the median finfold region (Figure 13A (a)). In a normally developing embryo, the median
of the finfold is clear and organized thing membrane around the trunk region which
contains unsegmented fin rays. However, in the abnormal finfold region, we observed
that the tissue is disorganized and the structure is altered. In the more severe deformed
embryos, the fin rays are severely misshaped and the shambolic. We also observed tail
and spinal cord flexures in most of the deformed embryos from all stages (Figure 13A
(a)). In normally developed embryos, the tail and spinal cord will develop straight to the
posterior-most tip of the tail. However, in those embryos treated with Ag+ ions, the tail
was often curved or flexed. In some more severe cases, the tail was extremely truncated
compared to normally developed embryos. These severities in the tail flexure usually
resulted from increased Ag+ ion concentrations.
Severity and other forms of observed deformities usually depended on the treated
developmental stage. Embryos treated with higher Ag+ ion concentrations in all stages
usually resulted in edema in the pericardial sac, the double-layered conical sac of fibrous
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tissue which surrounds the developing heart muscles. In normal embryos, the pericardial
sac is a thin membrane serving as a protective barrier to the developing heart. However,
observed swelling of this region resulted in enlargement of the heart muscles.
Additionally, enlargement of the yolk sac region was also observed. The yolk sac region
is a bulbous area containing nutrients needed for the developing embryo, which will
usually shrink during the development, as the embryo becomes less depended on those
nutrients. We, however, observed this region to be swollen after 120 h of treatment with
the Ag+ ions.
In the most severe cases, we observed head and eye abnormalities in those
embryos treated with Ag+ ions. In these cases, we observed smaller or irregularly we
observed either one or both lenses were altered. These cases were rarely observed, but
when present, was usually together with the other observed abnormities previously
mentioned.
Figure 13 shows the represented deformities shown in all treated stages. In
embryos treated in all stages, we observed all of the described abnormities (Figure 13 (ad)) with the finfold and tail flexures being common for the treated concentrations, where
most were found in the 0.10 and 0.20 µM treatment groups. For stages, I, II, and III, yolk
sac and pericardial sac edemas were commonly found in the 0.20 – 0.40 µM treatment
groups. In stage IV we observed pericardial sac edemas and yolk sac edemas in all
treated groups. In stage V, although rarely observed, we only saw the presence of all
categorized abnormalities in the higher concentrations.
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Figure 13: Representative optical images of deformities observed in stages I – V
after acute treatment with AgNO3.
(A) Stage I, (B) Stage II, (C) Stage III, (D) Stage IV, (E) Stage V represents deformed
zebrafish displaying (a) finfold abnormality; (b) tail/spinal cord flexures; (c) pericardia
malformation and yolk sac edema; (d) head and eye abnormality.

(F) Represents

normally developed Zebrafish larvae at 120 hpf. (G) Represents dead embryo after
treatment. Scale bar: 250 µm.
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shaped of tissues where defined craniofacial anatomy was clearly observed. The eyes
would become smaller in size compared to a normally developed embryo. In minor cases,
In stage III, we did observe more severe cases of tail curvatures and spinal cord
infractions in those higher concentrations of the Ag+ ions. This is significant in that stage
III is the early segmentation stage where the notochord and spinal cord are forming. The
phenotypes observed suggest that exposure to the Ag+ ions at this developmental stage
is highly influenced to result in tail malformation. Likewise, in stage IV, pericardial sac
edemas were prominent in all treated concentrations. These observed results suggest a
phenotypical depended occurrence in developing embryos when Ag+ ions are present.
Possible reasons for the high dependence of type and severity of defects on the stage of
development and concentration of Ag+ ions could be due to the following: (i) Ag+ ions
enter inside the chorion space of the embryo during the specific stage of development
and affect the specific proteins, signaling, and developmental pathways during that period
of development. (ii) An increase in the number of Ag+ ions inside the chorion space of the
embryo during the specific stage of development increases the altering effects of the
protein, signaling, and developmental pathways during development increasing severity
of the deformity observed or death.
Our results describe a range of developmental defects and absolute death
following exposure of developing zebrafish embryos to micromolar concentrations of Ag+
ions at particular embryonic stages of development. Specific developmental pathways of
embryonic development are still unknown, such as, differentiation into specialized tissues
and organs, specifically how cells communicate with each other, how they become
committed to a certain fate, and how they formulate a pattern to become a structure.

18,
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Stage-dependent developmental responses to Ag+ ions, shown here, in a

concentration-dependent manner, demonstrates the possibility of being able to pick
specific developmental pathways to create particular phenotypes and as potential
developmental therapeutic agents to treat specific disorders and generate specific
developmental mutation in zebrafish, by alteration of the time of application of the Ag+
ions.
Study of stage-dependent effects of Ag+ on embryonic cardiac development
As we observed pericardial sac edema and cardiac malfunctions in zebrafish treated with
silver ions, we further studied the effects of these ions on the cardiac function of zebrafish
after their exposure to the Ag+ ion compared with the controls at different time points.
Basically, individual myocardial cells begin to contract irregularly around the 22-somite
stage (21 hpf) giving heart rate at about 25 beats per minute. Heart rates dramatically
increase to about 90 beats per minute by 24 hpf when shortly thereafter blood circulation
begins. As the heart developed, morphological differentiation progresses in an arterial to
venous direction. The heart tube has looped and beat at higher rates to provide a strong
circulation to the trunk and head.

75, 76

In all stages, we found that the number of embryos with normal developed heart
decreased as the Ag+ ion concentration increased since some embryos exposed to Ag
ions were either dead or deformed. In normally developed zebrafish, heart rates
increased as the heart developed. Heart rates of normally developed zebrafish at 48 hpf
and 120 hpf were significantly greater than those at 24 hpf when the heart was at the
early developmental stage (Figure 14). However, Ag+ ions insignificantly reduced embryo
heart rates at 24, 48, and 120 hpf in a dose-dependent manner (Figure 14). In contrast,
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those cardiac deformed zebrafish at all concentrations surprisingly showed no significant
difference in heart rates over developmental periods. Their heart rates at 48 hpf and 120
hpf were at the same or lower than those at 24 hpf (Figure 14). This suggests that the
heart became increasingly deformed over time which could lead to lower heart rates, less
blood flow, and oxygen supply, and thus possibly contributing to mortality. Ag NPs have
previously shown to interfere with regular cardiac functions.44, 64, 77-79 Improper blood flow
could starve the cells of gases and essential nutrients, resulting in cell death.74, 80, 81
It is worth noting that the heart rates of cardiac deformed zebrafish were much
lower than zebrafish with normal cardiac development but not in a concentrationdependent manner. Although the mechanisms are still not well understood, Ag+ ions could
disrupt heart development contributing to heart deformities and then leading to the
depressed heart rates.
Specifically, we did not observe a significant difference between treated stages, as
all stages displayed similar heart rates, despite the differences in overall development
and toxicity, which showed a stage-dependent trend. Stage I – V (Figure 14 A-E) all
resulted in similar trends, where, the higher the Ag+ ion, the lower the heart rate recorded.
One notable difference we did observe was for stage IV (Figure 14 D) when it came to
those deformed zebrafish in the 1.20 µM treatment group. The heart rate for the deformed
embryos was noted to be significantly higher at 120 hpf. This could be influenced by
treatment at this particular developmental stage, where cardiogenesis is majorly affected
during the development of the heart muscles. More studies would need to be conducted
to further examine this phenomenon.
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Figure 14: Quantitative Heartbeat Analysis for specific developmental stages of
embryos.
Heartbeats were taken at 24, 48, and 120 hpf for all embryos. Based on development,
heartbeats per minute was graphed by concentration for (a) 24 hpf Normal, (b) 24 hpf
Deformed, (c) 48 hpf Normal, (d) 48 hpf Deformed, (e) 120 hpf Normal, and (f) 120 hpf
Deformed Analysis for (A) Stage I embryos, (B) Stage II, (C) Stage III, (D) Stage IV, (E)
Stage V.
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Study of stage-dependent hatched time of zebrafish upon Ag+ concentration
Zebrafish hatching is a vital step for survival. Longer hatching duration could leave
organisms to more susceptible to predators and if hatching is inhibited, embryos could be
die in their chorions.
16, 20, 22

14, 82

In fact, zebrafish hatching is associated with two processes.

Initially, the hatching enzyme from the hatching gland is released to break down

the inner vitelline envelope of the cellular chorion, and then the movement of the embryo
breaks the weaken chorion 39. Delayed hatching in response to Ag NP exposure has been
reported. For example, zebrafish had delayed hatching after exposure to 1 µM Ag NPs.
However, the occurrence of delayed hatching due to Ag+ ion exposure in zebrafish has
not yet been widely studied.
We studied the concentration-dependent effects of Ag+ ions on the hatching time
of zebrafish embryos (Figure 14) for each developmental stage. Embryos were exposed
to Ag+ ions with various concentrations (0-1.2 µM) in egg waters for 120 hr. The
developing zebrafish embryos were imaged and we monitored newly hatched embryos
over time at 4, 24, 48, 72, 96, and 120 hpf. The numbers of newly hatched embryos are
shown in Figure 9 for stages I - V. Embryos started to hatch at 48 hpf and the majority of
them hatched at 72 and 96 hpf. In all stages, the hatching of embryos was significantly
delayed by Ag+ ion exposure in a concentration-dependent manner. The embryos that
were exposed to higher concentrations of Ag+ ions had hatched later than the control and
those exposed to the lower Ag+ ion concentrations. For example, as shown in Figure 14A,
in stage I, at 72 hpf, the majority of control embryos hatched and the numbers of hatched
embryos decreased as the concentration increased while at 96 hpf, majority of the
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embryos exposed to low Ag ion concentrations (0.05 and 0.10 µM) hatched and at 120
hpf, most of the embryos exposed to high Ag+ ion concentrations (0.20-1.2 µM) hatched.
In stage III - V treated embryos, we observed a significant number of embryos
started to hatch at 60 hpf, which differs from stage I and II. This suggests that this
developmental time point results in treated embryos being less sensitive to the Ag+ ions
upon hatching. This difference may suggest that when treated at earlier developmental
stages, hatching is reasonably delayed to later time points when Ag+ ions are present,
exhibiting a stage dependent effect on hatching.
Mechanisms of Ag ions causing delayed hatch is still unclear. The delay possibly
associates with slowing maturation of the hatching grand, inhibition of hatching enzyme
and stunted growth and movement. Notably, zebrafish contains two zinc-based matrix
metalloproteinase enzyme genes (ZHE1 and ZHE2) and gene duplication events and
subsequent mutations lead to extremely low expression of ZHE2 and non-functioning of
hatching. Interestingly, a study showed that Ag+ ions did not interfere with ZHE1 activity
suggesting that the hatching delay could result from another injury mechanism. 39, 68
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Figure 15:

Rate of Hatched Zebrafish Exposed to Ag+ ions at specific

developmental stages.
The overall hatching rate of embryos were taken at 48, 60, 72, 96, and 120 hpf. Hatching
was reported by dilution of treated (a) 0.00 µM, (b) 0.10 µM, (c) 0.20 µM, (d) 0.3 µM, (e)
0.40 µM, (f) 0.80 µM, and (g) 1.2 µM AgNO3 for (A) Stage I embryos, (B) Stage II, (C)
Stage III, (D) Stage IV, (E) Stage V.
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SUMMARY
In summary, we have studied the toxicity of Ag+ ions on zebrafish embryos in vivo
at specific stages of development, aiming to assess nanotoxicity on embryonic
development, heart functions, and hatch time. Concentration-dependent, as well as
stage-dependent, toxic effects of the Ag+ ions on embryonic development, were
observed, showing that the number of zebrafish developed normally decreased while the
number of dead zebrafish increased as Ag+ ion concentrations increased. We observed
a phenotypical dependence of abnormal development upon developmental stage when
exposed to Ag+ ions. Many morphological defects were observed in the developing
embryo, including yolk sac edema, abnormal finfold and tail development, and cardiac
malformations at each stage of development, corresponding to the stage of treatment. In
general, the number of different types of defects and the severity of each varied with the
stage of treatment and increased with increasing concentration of Ag+ ions demonstrating
the possibility of selectively targeting specific embryonic developmental pathways by
altering the stage of development and dose of NPs for developmental therapeutic studies.
The Ag+ ions not only interfere with embryonic development but also heart development
and functions. We observed heart deformities and lower heart rates in zebrafish exposed
to Ag+ ions. Additional studies are necessary for elucidating the mechanism of Ag+ ion
induced heart deformities. Moreover, delays hatching in zebrafish were observed in a
dose-dependent manner. Zebrafish embryos exposed to high concentrations of Ag + ions
hatched later. The investigation of biocompatibility of silver ions, in comparison to the
study of metal and metal oxide nanomaterials in specific stages of development of
embryos can offer new knowledge about the developmental processes and environment,
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and provide new insights into the mechanics of the developing embryo as well as aid in
the finding for functional nano-developmental treatments for various disorders in early
development. The study of nanomaterials, as well as their bulk counterparts, can lead to
understanding their mechanism of toxicity, which is needed since they are increasingly
used in many areas of biomedical research.
MATERIAL AND METHODS
Breeding of zebrafish embryos
Wild-type adult zebrafish were housed in a stand-alone system (Aquatic Habitat).
They were maintained and bred as described previously. Briefly, we placed two pair
adults zebrafish in a clean 10-gallon breeding tank and used a light (14 h)-dark (10h)
cycle to trigger breeding and fertilization of embryos. We collected embryos at 2 hpf,
transferred them to a Petri dish, and well-rinsed them with egg water to remove
surrounding debris. The washed embryos were then used for the study of dosedependent toxicity of Ag+ on embryonic development. All experiments involving embryos
and zebrafish were conducted in compliance with IACUC guidelines (protocol # 15-012).
Treatment and monitoring of zebrafish embryos
Embryos were collected and transferred into a petri dish containing egg water
(1.2 mM NaCl), washed twice with egg water to remove the surrounding debris, and
placed into 48-well plates with each well containing one embryo in egg water. Sixteen
embryos were tested per concentration, per stage of development; each experiment was
repeated 3 times, totaling 48 embryos analyzed per concentration, per stage of
development. Treatment for each developmental stage is for 2 h, followed by a wash with
egg water, then placed in new wells for remaining of development. Embryos were directly
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imaged by bright-field optical microscopy using an inverted Zeiss Axiovert microscope
equipped with a 4x objective, CCD (Coolsnap, Roper Scientific) and a digital color camera
(Sony).
Study and characterization of toxicity of Ag+ on embryonic development
To study the concentration-dependent effects of Ag+ ion on embryonic
development, a dilution series of Ag+ ion treatment solutions (0, 0.10, 0.20, 0.30, 0.40,
0.80 and 1.20 µM) were incubated acutely with 5 stages of embryos in egg water for 2h.
Each experiment was carried out at least 3 times and a total number of embryos at 48
was studied for each individual concentration to gain representative statistics. Ag+ ion
concentrations were calculated to correspond to previous studied Ag NPs studies.
Embryos in egg water in the absence of Ag+ ion and in the presence of supernatant were
placed in 48-well plates as control experiments to probe the effects of possible trace
chemicals from NP synthesis. The embryos in the 48-well plates were incubated at
28.5C, and directly observed at room temperature using an inverted Zeiss Axiovert
microscope equipped with a digital color camera at 24, 48, 72, 96, and 120 hpf.
Data analysis and statistics
For the study of dose-dependent effects of NPs on embryonic development, a total
number of 48 embryos were studied for each NP concentration and each control
experiment over 120 hpf with a minimum of 12 embryos studied in each measurement.
We presented averaged the number of normally developed, dead and deformed zebrafish
vs. Ag+ concentration with standard deviations. We used conventional statistical analysis
methods (t-test, ANOVA, Tukey’s, SPSS Statistics with P = 0.05) to determine the
significance of the different observations between all concentrations for development,
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hatching, and heartrate results.
Deformities Histogram.

A Pairwise T-test comparison was performed of
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CHAPTER IV
STUDY OF STAGE DEPENDENT BIOCOMPATIBILITY AND TOXICITY OF SINGLE
42 NM SILVER NANOPARTICLES USING EARLY DEVELOPMENT OF ZEBRAFISH
EMBRYOS
INTRODUCTION
Nanoparticles (NPs), per their small size and unique physical properties, are ideal
for use in probing the nanoscale environments of living organisms, which enables the
study of a developing living organism at specific developmental stages of embryonic
development.72,

83-86

Single nanoparticles and their unique optical properties make

imaging in vivo more sensitive, allowing the transport of the NP in living vertebrates to be
monitored and offers new information on the developing mechanisms of the embryonic
organism. NP probes can be used in a variety of applications for new insight into
developmental processes, such as the improvement of screening tools in developmental
biology to investigate the embryonic innermost environment, to potentially control and
regulate certain processes in development, and to target specific system regulators for
biomedical biological uses.

Nanomaterials could demonstrate developmental stage-

dependent requirement of phenotypical morphology induced, suggesting that the
nanomaterials, at higher concentration, may interact with target developmental pathways
of interest.43, 64, 77, 87-89 In this study, we used our previously described nanomaterials,44
Ag NPs, and our effective embryo developmental model system, zebrafish embryos, to
focus on acute developmental stage-dependent biocompatibility and understand the
impact of nanomaterial exposure during embryogenesis and their mechanisms to induce
toxicity at specific development periods.
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Commonly, fluorescent probes have been used for probing and imaging in vivo
cellular pathways during embryonic development.90 However, using fluorescent probes
have their limitations because they will undergo photodecomposition, which limits the time
for intrusive analysis of the embryonic environment for specific stages of interest in realtime. Nanomaterials, such as quantum dots (QDs) and noble metal NPs (Ag, Au and
their alloys), are being used more as sensors for in vivo assays because they offer unique
properties that make them ideal for imaging.45, 47, 91-94 Though QDs have unique optical
properties compared to their fluorescent counterparts, they still experience a certain
extent of photodecomposition which still introduces a sense of variance from real-time
analysis.
Ag NP probes have unique optical properties over many fluorescent imaging
approaches because they have localized surface plasmon resonance (LSPR), enabling
characterization of their size and shape, and they offer high quantum yield (QY) of
Rayleigh scattering making them bright and easy to see using dark-field optical
microscopy and spectroscopy (DFOMS).60, 95-97 Ag NPs can be used as a probe for realtime study over an unlimited period of time because they do not experience
photodecomposition as fluorescent beads can. In addition, the LSPR spectra, or color of
the Ag NPs, can be used to show size-dependence.60, 95, 96 Using the LSPR spectra of
the multicolor Ag nanoparticles it is possible to be able to directly characterize the uptake
and diffusion of the same color nanoparticle at the nanometer scale in real-time, in
different biological environments based on using the same sized Ag NPs. 93, 98, 99
Zebrafish (Danio rerio) have been extensively employed as a well-studied
vertebrate model for embryological development because of its small size, its short
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breeding cycle, and the wealth of information available for manipulation.63, 70, 100-102 Its
transparency throughout development allows observation of all internal organ
development from outside the chorion without disturbing the living embryo. Zebrafish are
time efficient for care and maintenance and they effortlessly spawn in large numbers from
week to week producing macroscopic fertilized eggs, which are ideal for observing
different developmental stages. The embryonic development is so rapid that the first
stages of development are completed in the first 24 hours post fertilization (hpf) and the
normal embryo will hatch and swim by 72 hpf. The majority of developmental mutations
identified in zebrafish have close counterparts in other vertebrates, suggesting that this
system can be effectively used as a model for understanding the developmental
processes of higher organisms, including humans.66, 103 Therefore, zebrafish embryos
offer a unique opportunity to investigate developmental processes upon treatment with
NPs to investigate stage dependence NP effects on embryonic development.
Zebrafish have been used as a model organism for many chemical-screening and
drug studies, however, the acute biocompatibility on different zebrafish developmental
stages is not well studied.101,

104

The acute biocompatibility of Ag NPs on specific

sensitive stages of embryonic development has, to our knowledge, only been attempted
by our previous studies with smaller sized nanoparticles. It is important to explore the
biocompatibility of Ag NPs acutely at specific stages of embryonic development to access
the ability of Ag NPs to be used for in vivo imaging at any embryonic stage of development
as well as probes in real-time to explore the changing embryonic environment during
development, including cardiac influences and neurological changes.
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In this study, we have designed in vivo assays to study the biocompatibility of Ag
NPs in embryonic development to probe developmental changes that could help aid in
the investigation of molecular mechanism altered during nanoparticle exposure. We used
imaging assays and quantitative cardiac studies to probe the effects on zebrafish
embryos.
RESULTS AND DISCUSSION
Synthesis and characterization of Ag nanoparticles (NPs)
We used our previously developed sphere-shaped silver-based nanoparticles that
were washed and purified to study their interactions and biocompatibility with key stages
in developmental biology.

Thus, we can determine Ag NPs role in developmental

processes, including stage dependent and dose-dependent morphological responses, for
their potential use as developmental targeting probes for biomedical applications.44 We
characterized the stability, size and optical properties of the purified Ag NPs in egg water
embryo media (1.2 mM NaCl) for 120 h using UV-vis absorption spectroscopy, dark field
optical microscopy and spectroscopy (DFOMS) and high resolution transmission electron
microscopy (HRTEM).
We characterized the size of the Ag NPs using HRTEM and the size was with an
average diameter of 41.5 ± 7.6 nm (Figure 16). A representative optical image of Ag NPs
in Figure C illustrates that the majority of NPs appear to be blueish green to green, with
a few reds. These results suggest that Ag NPs are uniform in size and shape based on
their color (LSPR). The representative LSPR spectra of single blue, green and red Ag
NPs with peak wavelengths (λmax) at 498 nm (blue) (FWHM = 38 nm), 554 nm (green)
(FWHM = 47 nm), and 659 nm (red) (FWHM = 47) nm, respectively (Figure 16). Thus,
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the color of Ag NPs can be used as size index to directly distinguish and determine the
size of NPs using DFOMS, even though the size of NPs cannot be directly measured due
to the optical diffraction limit. We characterized the stability of Ag NPs in egg water for
120 hours, which is the length of embryonic studies. The results are given in Figure 17.
The absorbance spectra of freshly prepared and purified Ag NPs before and after the
incubation time with egg water demonstrated a peak wavelength (λmax) at 401nm (FWHM
= 56 nm) and remained unchanged for 120 hours (Figure 17 A). We found that the
number of NPs remained relatively unchanged when incubated in egg water for 120 h,
where the average of total number of NPs from triplicate runs at 0 h and 120 h is 2,044 ±
28, and 1,979 ± 12, respectively The unchanged number of NPs and stable absorbance
spectra indicates that the Ag NPs are very stable in egg water media and remain nonaggregated.
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Figure 16: Characterization of sizes, shapes, and plasmonic optical properties of
single Ag NPs.
(A) HRTEM image shows the spherical shape of single NPs. (B) Histogram of size
distribution of single NPs determined by HRTEM shows average diameters of 41.5 ± 7.6
nm. (C) Dark-field optical image of single NPs shows that a majority of NPs are plasmonic
green with some blue-green and red. (D) LSPR spectra of representative single NPs.
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Figure 17: Characterization of stability of Ag NPs in egg water (CNPs = 0.5 nM) for
120 h.
(A) UV-Vis absorption spectra of the NPs dispersed in egg water at 28.5 °C for (a) 0 and
(b) 120 h show that its peak absorbance of 401 nm (FWHM = 56 nm) remains unchanged
for 120 h. (B) The average of total number of NPs from triplicate runs at 0 and 120 h is
2,044 ± 28, and 1,979 ± 12, respectively. The 10 images are acquired at each given time
point using DFOMS.
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Exposure of Ag NPs to specific developmental stages of zebrafish embryos
Imaging and monitoring live animals throughout development provides a more
informative view of these biological events. That is why we selected zebrafish embryos
to serve as our animal model. Danio rerio embryos are prominent animal models for realtime analysis during embryogenesis.15, 21, 105 In fact, zebrafish have several noteworthy
advantages for live animal imaging in real time. Foremost, both adult and young zebrafish
can be easily maintained for imaging applications. Secondly, zebrafish are optically
transparent during early development and, as a result, optical imaging techniques can be
easily applied. Thirdly, zebrafish fertilization is external, which enables live animal
imaging during all stages of embryonic development. Finally, zebrafish have a high
homology with mammals.

Having these genetic similarities allows for complex

investigation to study those can be used to model biological defects that occur in higher
animals.
The normal course of embryonic development in zebrafish in the absence of NPs
for each acute treatment stage is depicted in Figure 18. Acute treatment occurred at five
different stages of development for a 2 h incubation time with NPs: stage I, cleavage
stage (2-4 hpf) (Figure 18 A), stage II, gastrula stage (6-8 hpf) (Figure 18 B), stage III,
early segmentation stage (12-14 hpf) (Figure 18 C), stage IV, late segmentation stage
(21-23 hpf) (Figure 18 D) and stage V, hatching period (48-50 hpf) (Figure 18 E). The
stages were determined by choosing critical events in embryonic development for
studying molecular mechanisms from exposure with NPs.

During stage I, embryos

undergo dramatic changes like rapid cellular division and embryonic pattern formation.61,
106

During stage II, embryos undergo cell movements and migration and establishment
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of the early organ systems. In stage III, embryos begin somitogenesis and notochord
formation, which is important for proper development of the axial skeleton, the vertebrate
spinal column, and the skeletal muscle.39,

68, 69

During stage IV, embryos undergo

development of the circulatory system and the heart is being formed.39, 68, 104 During stage
V, the embryo is in the hatching stage and finishing its development.
Danio rerio embryos exposed to a series concentrations of Ag NPs acutely at
select stages revealed that NPs induced death, as well as a variety of morphological
defects and the number of different types of defects and the severity of each increased
with increasing concentration of NPs. Results of overall morphology are presented in
Figure 19. Stage I resulted in an increasing percentage of deformities in Ag NP treated
embryos as the concentration was increased (Figure 18 A) with a critical concentration at
0.10 nM. This stage appeared sensitive to the treatment with NPs causing death of the
embryos.

In stage I, exposure to the lowest concentration even produced a small

percentage of abnormalities and death.

At higher concentrations, an increasing

percentage of Ag NP treated embryos died; correspondingly, recovery of viable
abnormalities also declined. At the highest tested concentration, a majority of embryonic
death was observed (Figure 19 A).
Embryos treated in stage II had a high rate of death but showed a low number of
deformities (Figure 19 B), correlating with increasing NP concentration and having a
critical concentration at 0.20 nM. This stage also appeared sensitive to the treatment with
NPs causing death of the embryos. This was specific for this stage of development and
most likely due to the fact that during this stage of development the embryos are
undergoing vast cellular movements and formation of the early organ systems. 107,

108
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During this period the germ layers of the embryos are also being established.107, 108 Stage
II of development is a time when the onset of gene expression is starting and cell
migration is prominent.

Exposure of the Ag NPs could affect the pathways during

development causing an increase in death at this stage, which is directly related to the
increase in the NP concentration.
Stage III resulted in an increasing number of embryonic death as the concentration
was increased (Figure 19 C) with a critical concentration is between 0.20 and 0.50 nM.
Exposure to the lowest concentration in stage III produced small quantities of
abnormalities. At the highest tested concentration, a total embryonic death was observed
(Figure 19 C).
Stage IV treated embryos resulted in increased deformities with the lowest
concentration and remained consistently constant throughout Ag NP concentration rises
(Figure 19 D). The critical concentration was determined to be 0.20 nM. In stage IV even
exposure to the lowest concentration produced abnormalities. At higher concentrations,
a small increasing percentage of Ag NP treated embryos died. At the higher tested
concentrations in stage IV, a majority of embryonic death was observed (Figure 19 D).
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Figure 18: Normally developed zebrafish at stages I – V at the time of acute
treatment and observations after acute treatment.
Representative optical images of normally developed zebrafish at the time of acute
treatment for stage I – V, (a) 2 hpf (cleavage stage); (b) 6 hpf (early gastrula stage); (c)
12 hpf (early segmentation stage); (d) 21 hpf (late segmentation stage) and (e) 48 hpf
(hatching stage). Scale bar = 500 µm.
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Histograms displaying the distribution of effects resulting from

treatment with Ag NPs and the supernatant on zebrafish.
(A) Normally developed, deformed, and dead zebrafish vs. concentration of Ag NPs in
stage I. (B) Normally developed, deformed, and dead zebrafish vs. concentration of Ag
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NPs in stage II. (C) Normally developed, deformed, and dead zebrafish vs. concentration
of Ag NPs in stage III. (D) Normally developed, deformed, and dead zebrafish vs.
concentration of Ag NPs in stage IV. (E) Normally developed, deformed, and dead
zebrafish vs. concentration of Ag NPs for stage V. (F) Normally developed and dead
zebrafish vs. concentration of supernatant removed from Ag NP washing.
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Stage V resulted in no morphological defects and only a slight increase in the death
rate (Figure 19 E) with a critical concentration between 0.20 nM and 0.50 nM. This is
possibly due to that during stage V, the embryo is in the hatching stage and finishing its
development.108 Untreated control embryos for stages I through V (0.00 nM) produced
no abnormal embryos and embryo viability was within normal limits (Figure 19 A-F).
Control embryos exposed to (nanoparticle-free) supernatant from the NP washing
process showed minimal levels of toxicity at all tested concentrations (Figure 19 F).
The effective dose for our acute studies was determined from our previous chronic
studies.42, 44, 64, 77, 78, 88, 109 We treated stage I through V embryos acutely with various
concentrations of Ag NPs (0.00 – 0.50 nM). Embryos were carefully monitored posttreatment at 24, 48, 72, 96, and 120 hpf. We examined the defects associated with the
treatment of developing embryos with Ag NPs at each treated developmental stage.
Many morphological defects were observed in the developing embryo, including abnormal
finfold and tail development, cardiac malformation (pericardial sac edema), yolk sac
edema, and head and eye abnormities as shown in Figure 20. Every treated stage
presented some abnormalities. The shared abnormality among stages I, II, IV, and V
treated embryos was finfold abnormalities, typically affecting the median finfold region
(Figure 20 A, B, D, E (a)). In normally developing embryos, the median finfold area is a
clear, thin membrane around the entire trunk region containing unsegmented fin rays.
69

65,

In treated embryos at these stages, the tissue structure of the finfold was disorganized

and in the more severe cases, the shapes of the finfold and the developing fin rays were
altered.
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Treated embryos from stages I, II, III, and V displayed as another common defect,
an abnormal tail (spinal cord) flexure phenotype (Figure 20 A-C, E (b)). This defect was
often accompanied by tissue abnormalities of the finfold. In normal developing embryos,
the notochord and spinal cord develop straight to the posterior-most tip of the tail. In the
treated embryos for these stages, however, the tail region was flexed to some extent. In
the more severely flexed embryos, the flexure was extreme and the overall length of the
tail was reduced (Figure 20 C (b)). The tail flexure defect also increased in severity with
increasing NP concentration.
Another commonly shared defect, which was presented in all stages, was
presented as a cardiac malformation. More specifically, we observed swelling of the
housing membrane where the ventral and artery bulbs develop and starts pumping,
resulting in pericardial sac edema. In contrast to normal embryos, in the stage I treated
embryos; the pericardial sac region was swollen and enlarged (Figure 20 A-E (c)). In
severe cases, the pericardial sac was extremely large and the cardiac ventricle was
decreased in size.
Yolk sac edemas were readily observed in stages II, IV, and V (Figure 20 B, D-E
(d)). In normally developing embryos, the yolk sac region is a bulbous area containing
yolk that provides nutrients to the developing embryo and during the later developmental
process, the yolk sac shrinks. In the affected treated embryos of these stages, however,
the yolk sac region was swollen and enlarged. This type of edema is a common defect
in treated embryos. It is thought that the dependence of the nutrients during treatment
blocks those enzymes responsible for decreasing this area.61, 63, 104, 110 Similar to our
previous studies and treatment with both Ag NPs and Ag+ ions, we see this type of defect
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combined with another type of deformities, normally, finfold abnormities and pericardial
sac edemas. This leads us to believe that this lack of shrinkage in an area important for
embryo survivability is highly influenced by the development of other major organs in the
zebrafish. If certain areas are not properly developed and outside nutrients cannot be
sought by on the embryo’s own, then the yolk sac will continue to serve as the embryos
main source of nutrients during development.
In stages III – V, we observed head and eye abnormalities (Figure 20 C-E (e)).
The heads of these abnormal zebrafish were smaller than, and not as round as, a normal
embryo would appear (Figure 20 F).

70

A

a

b

c

d

e

B
C
D
E

F

Figure 20: Representative optical images of deformities observed at 120 hpf in
stages I – V after acute treatment with Ag NPs.
Optical images of deforms observed :(a) finfold abnormality; (b) tail/spinal cord flexure;
(c) pericardial sac edema; (d) yolk sac edema and (e) head and eye abnormities. Stage
I (A), Stage II (B), Stage III (C), Stage IV (D), and stage V (E) images represent common
deformed found in each stage. (F) Normally Developed zebrafish. Scale bar = 500 µm.
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A histogram of the average number of embryos observed with different types of
deformities at each stage for treated Ag NPs concentrations is presented in Figure 21.
Here, we see that in stage I, the lowest Ag NP concentration, 0.02 nM, presented only
pericardial sac edemas, whereas 0.10 and 0.20 nM treatment groups presented tail
flexures and yolk sac edemas (Figure 21 A). For stage II, the lowest treated concentration
of Ag NPs where deformed zebrafish were observed was 0.05 nM. At this concentration,
only finfold abnormality was recorded. The higher concentrations all resulted in tail
flexures, pericardial sac edema, and/or head abnormality (Figure 21 B). For stage III, we
observed the most abnormal zebrafish from lower concentration groups, where multiple
defects were recorded for 0.02 and 0.05 nM (Figure 21 V). This, as a result, was the
most sensitive stage for this particular size of NPs. Stage IV presented few defects only
observed in the 0.10 and 0.20 nM treatment groups (Figure 21 D). Stage V, the hatching
stage, interestingly enough, presented many different types of deformities in the higher
treated concentrations (Figure 21 E). This is significant because, in other stages, these
type of deformed zebrafish did not survive in the higher treated group (0.20 and 0.50 nM).
The fact that these deformed zebrafish were able to survive after exposure is a manner
that needs to be further explored.
Possible reasons for the high dependence of type and severity of defects on the
stage of development and concentration of NPs could be due to the following: (i) The NPs
enter inside the chorion space of the embryo during the specific stage of development
and affect the specific proteins, signaling, and developmental pathways during that period
of development. (ii) An increase in the number of NPs inside the chorion space of the
embryo during the specific stage of development increases the altering effects of the
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protein, signaling, and developmental pathways during development increasing severity
of the deformity observed or death. Our results describe a range of developmental defects
and absolute death following exposure of developing zebrafish embryos to nanomolar
concentrations of Ag NPs at particular embryonic stages of development.

Specific

developmental pathways of embryonic development are still unknown, such as
differentiation into specialized tissues and organs, specifically how cells communicate
with each other, how they become committed to a certain fate, and how they formulate a
pattern to become a structure.107, 110 Stage-dependent developmental responses to Ag
NPs, shown here, in a dose-dependent manner, demonstrates the possibility of being
able to pick specific developmental pathways to create particular phenotypes and as
potential developmental therapeutic agents to treat specific disorders and generate
specific developmental mutation in zebrafish, by alteration of the time of application of the
NPs.
Quantitative heartbeat study of zebrafish upon Ag NPs concentration
As we observed pericardial sac edema and cardiac malfunctions in zebrafish treated with
Ag NPs during all stages of treatment, we further studied effects of Ag NPs on cardiac
functions of zebrafish after their exposure to NPs compared with the controls at three
different time points: 24 hpf (early heart formation period); 48 hpf (embryo hatching
period); and 120 hpf (full development period). We plotted the average heart rate per
minute for all treatment groups at each stage (line plots), along with the total number of
zebrafish analyzed (bar plots) (Figure 22 A-E). Essentially, individual myocardial cells
begin to contract irregularly around the 22-somite stage (21 hpf) giving heart rate at about
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Figure 21: Histograms of the types of deformities concentration of Ag NPs
treatment in zebrafish.
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Stage III (C), Stage IV (D), and stage V (E) images represent common deformed found
in each stage.

74

40-45 beats per minute. Heart rates dramatically increase to about 70-80 beats per
minute by 24 hpf when shortly thereafter blood circulation begins.

111

As the heart

develops, morphological differentiation progresses in an arterial to venous direction. The
heart tube has looped and beats at higher rates to provide a strong circulation to the trunk
and head. 111 Around 48 hpf, the observed normal beating heart of a zebrafish will roughly
be around 120 beats per minute. At 120 hpf, the will slightly increase in normal zebrafish
to roughly 150 beats per minute and will remain around this average until adulthood.
We found that the number of embryos with normally developed heart decreased
as the Ag NP concentration increased, resulting in a dose-dependent manner.

In

normally developed zebrafish, heart rates increased as the heart developed. Heart rates
of normally developed zebrafish at 48 hpf and 120 hpf were significantly greater than
those at 24 hpf when the heart was early developed (Figure 22 A-E). However, Ag NPs
insignificantly reduced embryo heart rates at 24, 48, and 120 hpf in a dose-dependent
manner at every stage (Figure 22 A-E). In contrast, cardiac malformed zebrafish found
after NPs exposure at all concentrations showed insignificant differences in heart rates
over the examined developmental periods. Their heart rates at 48 hpf and 120 hpf were
at the same or lower than those at 24 hpf. This suggests that the heart became more
deformed over time which could lead to lower heart rates, less blood and oxygen supply,
which possibly attributes to mortality. Ag NPs have previously shown to interfere with
regular cardiac functions

24,112.

Improper blood flow could starve the cells of gases and

essential nutrients resulting in cell death. It is worth noting that the heart rates of heart
deformed zebrafish were much lower than normal heart-developed zebrafish (Figure 22
A-E) but not in a dose-dependent manner. Although the mechanisms are still not well
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understood, Ag NPs could disrupt heart development contributing to heart deformities and
then leading to the depressed heart rates.
In stages I, II, and IV, we observed a huge decrease in the highest treatment group
(0.50 nM) at 48 hpf. This decrease shows that at this particular concentration, the effects
on the cardiac function was significantly influenced by the NPs presence. This is definitely
interesting to note, considering that these particular stages are highly significant for
proper development of the cardiovascular system, and cardiac function, as we can
observe, is particularly sensitive to any outside toxins. This can also coordinate with the
fact that pericardial sac edemas being the most common type of deformity resulting from
Ag NPs treatment.
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Figure 22: Quantitative Study of Heart Rates of Treated embryos per stage of
development.
Heart rates were measured for each treated embryo at 24 (a), 48 (b), and 120 (c) hpf and
represented by the lines. The average number of embryos for 24 (i), 48 (ii), and 120 (iii)
hpf are plotted in the bar graph. Stages I – V are shown here (A – E).
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SUMMARY
In summary, we examined the biocompatibility and toxicity of single Ag NPs in vivo
at specific stages of development and the defects associated with treatment at specific
developmental stages.

Increasing Ag NPs concentration resulted in all stages of

development resulted in a significant increase in embryonic death, and a correlated
decrease in survivability of normal and deformed zebrafish. Many morphological defects
were observed in the developing embryo, including yolk sac edema, abnormal finfold and
tail development, head and eye abnormalities, and cardiac malformations at each stage
of development, corresponding to the stage of treatment. In general, the number of
different types of defects and the severity of each varied with the stage of treatment and
increased with increasing dose of NPs demonstrating the possibility of selectively
targeting specific embryonic developmental pathways by altering the stage of
development and dose of NPs for developmental therapeutic studies. Moreover, it was
noted that at this particular size of single Ag NPs, cardiac malformation was significant
no matter the developmental stage. Pericardial sac edemas were one of the most
common types of deformity observed throughout the experiment.

In that matter,

quantitative analysis of cardiac function was found to be significantly influenced with
increasing Ag NPs concentrations. In particular, we saw a stage-dependent effect on
cardiac malformation, where stages I, II, and IV were highly influenced by exposure to a
higher dose of the Ag NPs. The investigation of biocompatibility of nanomaterials in
specific stages of development of embryos at single NP level can offer new knowledge
about the developmental processes and environment, and provide new insights into the
mechanics of the developing embryo as well as aid in the finding for function
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MATERIALS AND METHODS
Reagents and supplies
Sodium citrate (99%), AgClO4 (99%), NaBH4 (98%), and NaCl were purchased
from Sigma-Aldrich. All reagents were used as received. The nanopure water (18 M
water, Barnstead) was used to prepare all solutions and rinse glassware.
Synthesis and characterization of stable and purified Ag NPs
Ag NPs (41.5 ± 7.6 nm in diameter) were synthesized as we described previously.
Briefly, sodium citrate (10 mL, 34 mM) was quickly added into a refluxing (100C) AgNO3
aqueous solution (500 mL, 1.1 mM) under stirring. The mixture was refluxed and stirred
for 45 min, as the solution color turned from colorless to straw yellow, then opaque and
finally muddy yellow. The heating was stopped and the solution was cooled gradually to
room temperature under stirring. The NP solution was filtered using 0.22-µm filters. All
chemicals, except those indicated, were purchased from Sigma and used as received.
The NPs were immediately washed three times with nanopure DI water (18 M,
Barnstead) using centrifugation (Beckman, JA-14) to remove any residual chemicals
involved in NP synthesis. The washed NPs were resuspended in DI water and then egg
water. The washed NPs were very stable (non-aggregated) in DI water for months and
remained stable in egg water (1.0 mM NaCl, 99.95% Sigma, in DI water) throughout the
duration of the entire experiment (120 h, period of full embryonic development) (Figure
1). Concentrations of NPs were calculated, as we described previously.
Sizes of NPs were characterized using high-resolution transmission electron
microscopy (HR-TEM) (FEI Tecnai G2 F30 FEG) and dynamic light scattering (DLS)
(Nicomp 380ZLS particle sizing system). LSPR spectra and images of single NPs in
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solution, embryos and embedded in zebrafish tissues were acquired using dark field
optical microscopy and spectroscopy (DFOMS), which we described previously. In this
study, we used a charge coupled device (CCD) camera (Micromax, Roper Scientific) and
Multispectral Imaging System (Nuance, CRI) was used to acquire LSPR spectra of single
NPs.
Stability of NPs in solution and egg water was followed over time for 120 h using
UV-vis spectroscopy, DLS and DFOMS. The purified and stable NPs were used for
probing their diffusion into embryos and their effects on embryonic development.
Breeding of zebrafish embryos
Wild-type adult zebrafish (Aquatic Ecosystems) were housed in a stand-alone
system (Aquatic Habitats), and they were maintained and bred, as we described
previously. Briefly, two pairs of mature zebrafish were placed into a clean 10-gallon
breeding tank. A light (14 h)–dark (10 h) cycle was used to trigger breed and fertilization
of embryos. The embryos at the cleavage stage were collected and transferred into a
Petri dish containing egg water. They were well rinsed with egg water to remove any
possible debris prior to imaging and characterization. All experiments involving embryos
and zebrafish were conducted in compliance with IACUC guidelines (protocol # 15-012).
Treatment and monitoring of zebrafish embryos
Wild type adult zebrafish (Aquatic Ecosystems) were maintained, bred, and
collected, as described previously.44, 113 Embryos were collected and transferred into a
petri dish containing egg water (1.2 mM NaCl), washed twice with egg water to remove
the surrounding debris, and placed into 48-well plates with each well containing one
embryo in egg water.

16 embryos were tested per concentration, per stage of
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development; each experiment was repeated 3 times, totaling 48 embryos analyzed per
concentration, per stage of development. Each developmental stage of embryos in the
wells was directly imaged by bright-field optical microscopy using an inverted Zeiss
Axiovert microscope equipped with a 4x objective and a digital color camera.
Study and characterization of transport and biocompatibility of NPs
To study the dose-dependent effects of NPs on embryonic development, a dilution
series of washed Ag NP solutions (0, 0.02, 0.05, 0.10, 0.20 and 0.50 nM) were incubated
acutely with 5 stages of embryos in egg water for 2h. Each experiment was carried out
at least 3 times and a total number of 48 embryos were studied for each individual
concentration to gain representative statistics. NP concentrations were calculated as
described previously.44 Embryos in egg water in the absence of NPs and in the presence
of supernatant were placed in two rows of the 48-well plates as control experiments to
probe the effects of possible trace chemicals from NP synthesis. The embryos in the 48well plates were incubated at 28.5C, and directly observed at room temperature using
an inverted Zeiss Axiovert microscope equipped with a digital color camera at 24, 48, 72,
96, and 120 hpf.
Quantitative heartbeat study of zebrafish upon Ag NPs concentration
Both treated and control embryos for stages I - V were analyzed for heart rates.
Embryos were recorded using the Sony camcorder and Coolsnap Ez (Roper Scientific)
using 100 frames with a 50 ms interval delay. The recordings were taken at 24, 48, and
120 hpf. The movies were then converted and analyzed for manual counting of the hearts
contractions. The heartbeat per minute was then compared graphically to both the normal
and abnormal developed fish at each concentration.
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Data analysis and statistics
A minimum of 100 Ag NPs was imaged and characterized for each measurement
of their sizes and stability in egg water using HRTEM and DFOMS. A minimum of 300
NPs in total was studied for each sample via three repeated measurements. For the
study of dose-dependent effects and qualitative heart rate analysis of NPs on embryonic
development, a total number of 48 embryos were studied for each NP concentration and
each control experiment over 120 hpf with a minimum of 12 embryos studied in each
measurement. We presented averaged the number of normally developed, dead and
deformed zebrafish vs. Ag+ concentration with standard deviations.

We used

conventional statistical analysis methods (t-test, ANOVA, Tukey’s, SPSS Statistics with
P = 0.05) to determine the significance of the different observations between all
concentrations for development, hatching, heartrate and uptake results. A Pairwise Ttest comparison was performed of Deformities Histogram.
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CHAPTER V
STUDY OF EFFECTS OF SILVER NANOPARTICLES ON EARLY NEUROLOGICAL
DEVELOPMENT OF ZEBRAFISH EMBRYOS
INTRODUCTION
Our lab has previously demonstrated that stable purified silver nanoparticles can
induce unique and rare abnormalities in developing embryos.

114-118

The abnormal

phenotypes in development included cardiac malformations, abnormal tail and spinal cord
formation, and head and severe eye abnormalities. We wanted to understand more about
how and why these unique phenotypes occur from exposure to silver nanoparticles,
understanding the molecular mechanisms that are involved and identify primary biological
biomarkers that are highly influenced during embryogenesis from this induced
nanotoxicity.
The development of the brain and all of its mysteries is still an area that needs to
be explored. Neurological development is a well-regulated and regionalized operation
that is highly complex during embryogenesis. 119 Studies show that the formation of the
embryonic brain requires interaction from many essential biomarkers and inductive
interactions between different regions of the developing embryo.

In recent genetic

studies, some of these key biomarkers that play important roles within the developmental
process have been recognized, but exact mechanisms are still being explored. Some of
these biomarkers include the signaling molecules like noggin and follistatin, and the
regulating transcription factors otx, emx, pax, and engrailed genes. Although the genetic
assay approach allows for detailed genetic information to be discovered, this approach
still limits the understanding of mechanisms and the dynamics of these biomarkers in real
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time. They limit the view of understanding in cases where the molecular process is trying
to be correlated. We aim to approach this with a different strategy that allows us to study,
in real time, how these key biomarkers are influenced during development by
nanotoxicity.
To approach this, we chose to identify a key neurological protein biomarker that
has shown to have fundamental responsibility during neurological development. Pax2a
gene is a prominent protein that plays important roles in central and peripheral nervous
system development.
Paired box gene 2a (pax2a) is highly expressed during the segmentation stage of
development, largely involved in the formation of the midbrain-hindbrain boundary. This
region of the developing embryonic brain is essential to pattern formation and
organization of neural networks in both adjacent midbrain and hindbrain zones. Pax2a is
also uniquely expressed during eye and ear morphogenesis and has been shown to be
involved in multicellular organism development, like kidney, locus cerebellum formation,
otic placode formation, peripheral and central nervous system development, and
pronephros development.

120, 121

Transgenic zebrafish models expressing the pax2a

gene have been used to study the developmental migration of neuronal cells as well as
targeted for toxicological studies.122-127 This biomarker is important in this study because
mutations in the pax2a gene results in abnormal phenotypes in developing embryos that
showed similarities to those induced in our nanotoxicity studies.120-122, 128
Nanoparticles (NPs) are ideal for biomedical research in developmental biology
because of their unique capability in probing the nanoscale environments of living
organisms, enabling the study of a developing organism at different developmental
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stages.72, 83-86 Their unique optical properties makes imaging in vivo more convenient,
allowing the transport and diffusion of the NP to be monitored and offers new information
on the developing fluid mechanics of the embryonic organism. NP probes can be used
in a variety of applications for new insight into developmental processes, such as
development screening tools in developmental biology to investigate the embryonic
internal environment, to potentially control and regulate certain processes in
development, and to target specific system regulators for biomedical biological uses.
Nanomaterials could possibly demonstrate developmental stage-dependent regulation of
deformity type induced, suggesting that the nanomaterials, at higher concentration, may
interact with target developmental pathways of interest. In this study, we used our
previously described nanomaterials,44 Ag NPs, and an effective embryo developmental
model system, zebrafish embryos, and focused on biocompatibility targeting important
transgenic developmental in vivo models for analysis and independent NP entry into each
embryonic stage, hoping to identify possible developmental stage applications and the
ability for NPs to enter the developing embryo independent of the time of development.
Ag NP probes have unique optical properties over many fluorescent imaging
approaches because they have localized surface plasmon resonance (LSPR), enabling
characterization of their size and shape, and they offer high quantum yield (QY) of
Rayleigh scattering making them bright and easy to see using dark-field optical
microscopy and spectroscopy (DFOMS).60, 95-97 Ag NPs can be used as a probe for realtime study over an unlimited period of time because they do not experience
photodecomposition as fluorescent beads can. In addition, the LSPR spectra, or color of
the Ag NPs, can be used to show size-dependence.60, 95, 96 Using the LSPR spectra of
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the multicolor Ag nanoparticles it is possible to be able to directly characterize the
diffusion of the same color nanoparticle at the nanometer scale in real-time, in different
biological environments based on using the same sized Ag NPs.93, 98, 99
Zebrafish (Danio rerio) have been extensively employed as a well-studied
vertebrate model for embryological development because of its small size, its short
breeding cycle, and the wealth of information available for manipulation.63, 70, 100-102 Their
transparency throughout development allows observation of all internal organ
development from outside the chorion without disturbing the living embryo. Zebrafish are
time efficient for care and maintenance and they effortlessly spawn in large numbers from
week to week producing macroscopic fertilized eggs, which are ideal for observing
different developmental stages. The embryonic development is so rapid that the first
stages of development are completed in the first 24 hours post fertilization (hpf) and the
normal embryo will hatch and swim by 72 hpf. The majority of developmental mutations
identified in zebrafish have close counterparts in other vertebrates, suggesting that this
system can be effectively used as a model for understanding the developmental
processes of higher organisms, including humans.66, 103 Therefore, zebrafish embryos
offer a unique opportunity to investigate developmental processes upon treatment with
NPs to investigate stage dependence NP effects on embryonic development.
It is important to explore the biocompatibility of Ag NPs during embryonic
development to access the ability of Ag NPs to be used for in vivo imaging at any
embryonic stage of development as well as probes in real-time to explore the changing
embryonic environment during development, including neurological changes and
understanding mechanism in brain development.
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This study aimed to understand in real time how a key neurological developmental
biomarker is influenced in the presence of Ag NPs, thus allowing us to explore their
mechanisms and roles during embryogenesis. We designed an ultrasensitive in vivo
bioanalytical imaging tool to study molecular changes at the single cell resolution of cells
expressing Pax2a protein biomarkers. Using transgenic zebrafish models, we were able
to determine the effects of Ag NPs and understand how nanotoxicity can influence the
molecular mechanism of these protein biomarkers in expressing cells at various stages
of embryogenesis.
To that end, we selected a vital protein biomarkers that play important roles in
neurological development, used transgenic embryos that express the protein biomarkers
fused with fluorescence proteins as model organisms, and studied the effects of NPs on
their functions using fluorescence microscopy and plasmonic spectroscopy.
RESULTS AND DISCUSSION
Synthesis and characterization of Ag nanoparticles (NPs)
Ag NPs were synthesized, purified and characterized, as described in Methods.
Notably, highly purified Ag NPs were produced by thoroughly washing Ag NPs with
deionized (DI) water to remove potential residual chemicals involved in NP synthesis via
centrifugation. A representative optical image of Ag NPs in Figure 23 C illustrates that
the majority of NPs appear to be blueish green to green, with a few reds. These results
suggest that Ag NPs are uniform in size and shape based on their color (LSPR). The
representative LSPR spectra of single blue, green and red Ag NPs with peak wavelengths
(λmax) at 468 nm (blue) (FWHM = 38 nm), 554 nm (green) (FWHM = 47 nm), and 659 nm
(red) (FWHM = 47) nm, respectively (Figure 23). Thus, the color of Ag NPs can be used
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as size index to directly distinguish and determine the size of NPs using DFOMS, even
though the size of NPs cannot be directly measured due to the optical diffraction limit.
The NPs were then suspended in egg water (1.0 mM NaCl, embryonic medium) for the
study of their stability and their effects on embryonic development. We characterized the
stability, size and optical properties of the purified Ag NPs in egg water embryo media
(1.0 mM NaCl) for 120 h using UV-vis absorption spectroscopy, dark field optical
microscopy and spectroscopy (DFOMS) and high-resolution transmission electron
microscopy (HRTEM). The size was with an average diameter of 41.5 ± 7.6 nm (Figure
23). We found that the number of NPs remained relatively unchanged when incubated in
egg water for 120 h. The absorbance spectra of freshly prepared and purified Ag NPs
before and after the incubation time with egg water demonstrated a peak wavelength
(λmax) at 401 nm (FWHM = 52 nm) and only showed a slight decrease in absorbance for
120 hours (Figure 23). The unchanged number of NPs and stable absorbance spectra
indicates that the Ag NPs are very stable in egg water media and remain non-aggregated
throughout the entire experiment.
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Figure 23: Characterization of sizes, shapes, and plasmonic optical properties of
single Ag NPs.
(A) Dark-field optical image of single NPs shows that a majority of NPs are plasmonic
green with some blue-green and red. (B) LSPR spectra of representative single NPs (C)
HRTEM image shows the spherical shape of single NPs. (D) Histogram of size distribution
of single NPs determined by HRTEM shows average diameters of 41.5 ± 7.6 nm.
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Figure 24: Characterization of stability of Ag NPs in egg water (CNPs = 0.5 nM) for
120 h.
(A) UV-Vis absorption spectra of the NPs dispersed in egg water at 28.5 °C for (a) 0 and
(b) 120 h show that its peak absorbance of 401 nm shows only a slight decrease after
incubation r for 120 h. (B) The average of total number of NPs from triplicate runs at (a)
2 h, (b) 48 h, and (c) 120 h in both egg water and deionized nanopure water. The average
total number of NPs is 501, 520, and 492, respectively in egg water, and 475, 474, and
510 respectively in nanopure water. The 10 images are acquired at each given time point
using DFOMS.
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Early-development transgenic embryos as ultrasensitive in vivo assays
Optical images in Figure 25 A shows normal developmental stages of zebrafish
embryos, which includes cleavage (0.75-2.25 hours-post-fertilization, hpf), early
segmentation (12 hpf), late segmentation (24 hpf), hatching stages (48 hpf and 72 hpf
and a fully developed zebrafish (120 hpf).

All embryonic developmental stages of

zebrafish are well defined. 40, 66, 68, 103 The earlier developmental stage, such as cleavage
stage, is likely more prone and sensitive to the effects of external substances (e.g., drugs,
NPs) than later stages. Notably, during the cleavage-stage embryos undergo drastic
changes to lay down the foundation for developing different organs. Their related and
important developmental mechanisms remain not yet fully understood.59, 100, 101 Thus, we
select cleavage-stage embryos for the study of biocompatibility and toxicity of NPs,
aiming to develop ultrasensitive in vivo assays for effectively screening of NPs and to
rationally design biocompatible NP probes for in vivo imaging.
Study of dose-dependent biocompatibility and toxicity of NPs and control
experiments
We studied dose-dependent toxic effects of NPs on embryonic development by
incubating cleavage-stage embryos with various concentrations (0- 5.00 pM) of Ag NPs
suspended in egg waters for 120 h. Representative embryonic developmental stages
were imaged and assayed over time until the embryos were fully developed. The number
of embryos that developed to normal zebrafish (Figure 25 A), became dead (Figure 25
B), and deformed zebrafish (Figure 26 B) were recorded.
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Figure 25: Study of dose-dependent effects of Ag NPs on embryonic development
using embryos as ultrasensitive in vivo assays.
(A) Optical images of normally developing embryos at (a) cleavage-stage (0.75-2.25 hpf);
(b) late gastrula stage (10 hpf); (c) late segmentation stage (24 hpf); (d) hatching stage
(48 hpf); (e) 72 hpf hatched embryo; (f) fully developed larvae (120 hpf). (B) Dead
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embryo.

(C) Histograms of distributions of embryos that developed to normal and

deformed zebrafish or became dead versus NP concentration. (D) Control experiments:
histograms of the distributions of embryos that developed to normal zebrafish or became
dead either in egg water alone or versus concentration of supernatant, which was
collected from the last washing of NPs with DI water. A total of 48 embryos were studied
for each NP concentration and control in
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Figure 26: Dependence of types of deformed zebrafish on NP concentration.
(A) Optical image of a normally developed Zebrafish Larvae at 120 hpf. (B) Optical
images of deformed zebrafish show: (a-b) head and eye abnormities; (c-d) pericardial sac
and yolk sac edema; (e) tail/spinal cord flexure; and (f) finfold abnormalities.

(B)

Histograms of distributions of embryos that developed to deformed zebrafish with six
distinctive types of deformities at NP concentration of 0.5, 1.0, 2.0 and 5.0 pM. Scale bar
is 500 µm for all images in (A) and (B).
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Similar to our chronic study using similar sizes on wild type zebrafish embryos, the
effects of 43 nm Ag NPs on pax2a transgenic embryos resulted in dose-dependent
toxicity, as well as phenotypical dependent effect upon exposure to Ag NPs. This, again,
shows that the larger NPs are more toxic than smaller NPs.
Expression of pax2a:GFP in Ag NPs treated embryos
Treated transgenic embryos that were positive for the GFP protein was
imaged for their protein expression at key developmental time points during brain
development, shown in Figure 27. In the normally developed zebrafish, we observed the
expression of pax2a:GFP to decrease during brain development. This correlates with the
function of the pax2a gene. In fact, the analysis of the pax2.1 gene in zebrafish shows
embryonic expression pattern and requirement is regulated after brain development.
126

120,

The pax2a:GFP expression is most significant during early brain development, during

the midbrain-hindbrain boundary constriction. 129 Figure 28 shows examples of the GFP
expression during 15 hpf (A), 24 hpf (B), and 48 hpf (C).
intensity of the GFP embryonic expression at 24 hpf.

Figure

29

shows

the

Here, we observed that in

expression intensity decreased slightly as the Ag NPs concentration increase in normally
developed zebrafish. However, we did not observe this decrease to be significantly
different from our control embryos. These results may show that the pax2a gene is not
greatly affected by exposure of Ag NPs, however, other upregulated genes might still be
hugely affected, considering the phenotypical morphologies we see from treated
embryos. This in vivo assay may be used to explore those genes in more details
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Figure 27: Representative images of Expression of Tg(pax2a:GFP) in developing
embryos exposed to Ag NPs.
Fluorescence imaging of the expression patterns of the zebrafish embryos captured at
(A) 15 hpf, (B) 24 hpf, (C) 48 hpf, (D) 72 hpf, (E) 96 hpf, and (F) 120 hpf for all NPs treated
concentrations of (a) 0.00 pM, (b) 0.50 pM, (c) 1.00 pM, (d) 2.00 pM, and (e) 5.00 pM.
Expression is shown in the midbrain, hindbrain regions, and along the spinal cord of the
growing zebrafish. Expression does decrease over time. Imaging was captured using a
Coolsnap HQ (Photometrics) CCD using 4x objective and GFP (455 ex /505 dclp/525 em)
custom cube.
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Figure 28: Development of Tg(pax2a:GFP) embryos at 1 key developmental stages
of brain development.
Optical (a) and Fluorescence (f) imaging of embryos at different developmental time
points; (A) 15 hpf, (B) 24 hpf, and (C) 48 hpf. Expression patterns are found along the
midbrain and hindbrain areas during brain development.

The midbrain-hindbrain

segmentation can clearly be observed from the expression of GFP.
captured using a Coolsnap HQ (Photometrics) CCD using 10x objective.

Imaging was
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Figure 29: Expression of pax2a:GFP protein in zebrafish embryos at 24 hpf.
(A) Representative 10x images of 24 hpf embryos. (a) Optical image of a 24 hpf 0.00 pM
control embryo (b) Fluorescence image of a 24 hpf 0.00 pM control embryo (c) Optical
image of a 24 hpf 5.00 pM control embryo (f) Fluorescence image of a 24 hpf 5.00 pM
control embryo. Imaging of the expression patterns was captured in the hindbrain area
beside the optic placode. Imaging was captured using a Coolsnap HQ (Photometrics)
CCD using 10x objective. (B) Histogram of

GFP intensity plotted in over different
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treatments at 24 hpf in treated embryos; (a) Individual normally developed 0.00 pM
embryos fluorescent intensity, (b) Individual normally developed 0.50 pM embryos
fluorescent intensity, (c) Individual normally developed 1.00 pM embryos fluorescent
intensity, (d) Individual normally developed 2.00 pM embryos fluorescent intensity, (e)
Individual abnormally developed 2.00 pM embryos fluorescent intensity, (f) Individual
normally developed 5.00 pM embryos fluorescent intensity, (g) Individual abnormally
developed 5.00 pM embryos fluorescent intensity. Scale bar for images in (A) was 350
µm.
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Quantitative heartbeat study of zebrafish upon Ag NPs concentrations.
With many of the Ag NPs treated zebrafish resulting in pericardial sac edemas,
along with other cardiac malfunctions, we further monitored the effects of Ag NPs on heart
function of developing zebrafish. We compared those treated with Ag NPs with control
zebrafish at three major developmental time points: 24 hpf (early heart formation period);
48 hpf (embryo hatching period); and 120 hpf (full development period). We found that
the number of embryos with normal developed heart decreased as the Ag NPs
concentration increased since some embryos exposed to Ag NPs became either dead or
deformed. In normally developed zebrafish, heart rates increased as the heart developed.
Heart rates of normally developed zebrafish at 48 hpf and 120 hpf were significantly
greater than those at 24 hpf when the heart was in early cardiogenesis development
(Figure 30 A). However, Ag NPs significantly reduced embryo heart rates at 24, 48, and
120 hpf in a dose-dependent manner (Figure 30 A). In contrast, deformed zebrafish found
after Ag NPs exposure at 1.00 – 5.00 pM concentrations showed a significant difference
in heart rates over developmental periods. Their heart rates at 48 hpf and 120 hpf were
at the similar to those at 24 hpf (Figure 30 B) in normal embryos. Ag NPs have previously
shown to interfere with regular cardiac functions.

24,112

Significantly enough, we noted

that the heart rates of heart deformed zebrafish were much lower than normal heartdeveloped zebrafish (Figure 30 B) but not in a dose-dependent manner.
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Figure 30: Quantitative analysis of heartbeat of normally developed and heart
deformed zebrafish.
Plots of heartbeat per minute of normally developed zebrafish (A) and of deformed
zebrafish (B) at (a) 24 hpf which is an early stage of heart development, (b) 48 hpf which
is a hatching stage, and (c) 120 hpf when zebrafish fully developed versus Ag NPs
concentrations. Histogram (secondary axis) presents the total numbers of zebrafish from
three replicates used for heartbeat analysis at 24 hpf (i), 48 hpf (ii), and 120 hpf (iii).
Comparison of heartbeats between normal and deformed zebrafish (C) demonstrates that
heartbeat of the normal zebrafish at (a) 24 hpf, (b) 48 hpf, and (c) 120 hpf are higher than
deformed zebrafish (a’) 48 hpf and (b’) 120 hpf. Note that there were no deformed
zebrafish present at 24 hpf.
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Dose-dependent exposure to Ag NPs on optical development
Because head and eye abnormalities are readily recorded from exposure of single
Ag NPs from different sizes, an assay designed to analyze the craniofacial development
in zebrafish was explored. Analysis of the fully developed zebrafish optic area was
observed at 120 hpf. Eye measurements were plotted for all normally and abnormally
developed zebrafish.

Figure 31 A shows the optical examples of how these

measurements were taken, as further described in the Methods section. We observed
that as the concentration of the Ag NPs increased, the average size of the eye area of
both normal and deformed zebrafish larvae decreased, where 5.00 pM showed the
smallest size. Notably, those zebrafish that were deformed showed a significantly smaller
size of the eye area. Microphthalmia, the condition of reduced eye sizes in developing
embryos, can occur as a consequence of several developmental mechanism including
increased cell death or reduced cell proliferation in the developing eye. 130 This condition
in zebrafish has also affected behavioral response to light stimulation during behavioral
studies.

131

In fact, microphthalmia is associated with contralateral brains structural

abnormities, resulting in unresponsive optical development.
Our results show that Ag NPs exposure highly influences the development of the
eye and other craniofacial areas, which can have permanent effects in the adult zebrafish.
Further research will need to be applied to investigate the mechanism that is responsible
for this developmental delay.
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Figure 31: Zebrafish embryos exposed to Ag NPs result in microphthalmia after 120
h incubation.
Analysis of eye measurements of Zebrafish at 120 hpf. The yellow dashed outlines
highlights measured areas taken for each embryo. (A) Representative 10x images of 120
hpf zebrafish. (a) 0.00 pM normally developed embryo (b) 5.00 pM abnormally developed
embryo. Imaging was captured using a Coolsnap HQ (Photometrics) CCD using 10x
objective. (B) Histogram of GFP intensity plotted in over different treatments at 24 hpf in
treated embryos;

(a) Individual normally developed 0.00 pM embryos fluorescent
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intensity, (b) Individual normally developed 0.50 pM embryos fluorescent intensity, (c)
Individual normally developed 1.00 pM embryos fluorescent intensity, (d) Individual
normally developed 2.00 pM embryos fluorescent intensity, (e) Individual abnormally
developed 2.00 pM embryos fluorescent intensity, (f) Individual normally developed 5.00
pM embryos fluorescent intensity, (g) Individual abnormally developed 5.00 pM embryos
fluorescent intensity. Scale bar for images in (A) was 350 µm.
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Quantitative study of accumulation of Ag NPs in developing zebrafish embryos
Our previous studies have shown how different sizes of Ag NPs can diffuse into
different locations of a developing zebrafish after chronic and acute exposure. Here, we
quantitatively plotted the uptake of Ag NPs during chronic exposure to Ag NPs. Figure
32 shows the amount of Ag NPs in pmoles that was removed by normal, deformed, and
dead embryos. As noted, we observed a dose-dependent trend of uptake of Ag NPs in
treated embryos as the concentration of the NPs increased. In those embryos that were
deformed or dead during treatment, the amount of Ag NPs was significantly higher than
those that developed normally. These normally developed embryos also were more
apparent in normal embryo behavior like hatching from the embryos protective barrier,
the chorion, and swimming reflexes. We observed those embryos who were developed
abnormally had delayed hatched response, hatching at time points later than normal
range of 48 – 72 hpf. It is also notable that those embryos who did not survive during
treatment still resulted in higher NPs uptake.

This increased uptake significantly

corresponds to the mortality rate displayed in Figure 25.
This might be because those normally developed embryos were more resistant to
the diffusion of the NPs. These results are similar to uptake studies of commercial metal
and metal oxide nanoparticles when acutely exposed at much higher rates.
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This

proves the need to observe and study the uptake of nanomaterials during toxicity studies,
and to further study the molecular mechanisms that could potentially be responsible for
this uptake.
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Figure 32: Quantitative study of accumulation of Ag NPs in normally developed and
deformed zebrafish after treatment.
Plot of the amount of Ag NPs in embryos of single larvae (A) and of average accumulation
for each treatment group (B) after 120 hpf. Solution from each individual well was
collected at the start and end of treatment and the absorption, measured using UV-Vis
spectroscopy, was used to calculate the number of nanoparticles that accumulated in the
embryos during treatment. Plot shows the results for the normal, deformed, and dead
zebrafish.
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SUMMARY
Embryonic neurological development composes of many different components
that all work in unison to develop a functional pathway of neurological function. This study
objectively aimed to solidify a more cohesive understanding of how the pax2a functional
pathway operates, while at the same time explores how nanotoxicity can inhibit or
influence the behavior of these pathways. We found that exposure of Ag NPs (41.5 ± 7.6
nm in diameter) have a dose-dependent effect on Tg(pax2a:GFP) embryos during
embryogenesis. Sublethal concentrations of the Ag NPs also showed a phenotypical
dependent morphological effect during development. However, we did not observe a
significant decrease in expression of GFP when exposed to Ag NPs. We observed that
a higher dose of the Ag NPs leads to severe deformities. We also demonstrated the
effects of Ag NPs on cardiac response during exposure. We observed that Ag NPs can
decrease the heart rate of both normal and deformed zebrafish.

This study also

demonstrated dose-dependent effects of Ag NPs on eye development, where higher
concentrations of the Ag NP lead to microphthalmia. We also designed an in vivo assay
to study the uptake of Ag NPs in developing embryos. Here, we observed a significant
difference in uptake of those embryos that developed abnormally or who did not survive
during treatment.
This study emphasized different in vivo assays that can be explored to gain more
knowledge on neurological development in zebrafish, which can lead to better design or
more biocompatible biosensors to explore therapeutic and molecular assays of
embryogenesis and neurological diseases.
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METHODS
Reagents and supplies
Sodium citrate (99%), AgClO4 (99%), NaBH4 (98%), and NaCl were purchased
from Sigma-Aldrich. All reagents were used as received. The nanopure water (18 M
water, Barnstead) was used to prepare all solutions and rinse glassware.
Synthesis and characterization of Ag nanoparticles (NPs)
We used our previous developed sphere-shaped silver-based nanoparticles that
were washed and purified to remove any chemicals that remained from the synthesis to
study their interactions and biocompatibility to determine Ag NPs role in developmental
processes, including concentration-dependent morphological responses, for the potential
of use as developmental intermediates for biomedical applications.44 We characterized
the stability, size and optical properties of the purified Ag NPs in egg water embryo media
(1.2 mM NaCl) for 120 h using UV-vis absorption spectroscopy, dark field optical
microscopy and spectroscopy (DFOMS) and high resolution transmission electron
microscopy (HRTEM). The size was with an average diameter of 41.5 ± 7.6 nm (Figure
21 ). A representative optical image of Ag NPs in Figure 21C illustrates that the majority
of NPs appear to be blueish green to green, with a few reds. These results suggest that
Ag NPs are uniform in size and shape based on their color (LSPR). The representative
LSPR spectra of single blue, green and red Ag NPs with peak wavelengths (λmax) at 468
nm (blue) (FWHM = 38 nm), 554 nm (green) (FWHM = 47 nm), and 659 nm (red) (FWHM
= 47) nm, respectively (Figure 21). Thus, the color of Ag NPs can be used as size index
to directly distinguish and determine the size of NPs using DFOMS, even though the size
of NPs cannot be directly measured due to the optical diffraction limit. We found that the
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number of NPs remained relatively unchanged when incubated in egg water for 120 h.
The absorbance spectra of freshly prepared and purified Ag NPs before and after the
incubation time with egg water demonstrated a peak wavelength (λmax) at 401 nm (FWHM
= 52 nm) and only showed a slight decrease in absorbance for 120 hours (Figure 22).
The unchanged number of NPs and stable absorbance spectra indicates that the Ag NPs
are very stable in egg water media and remain non-aggregated throughout the entire
experiment.
Synthesis and characterization of stable and purified Ag NPs
Ag NPs (41.5 ± 7.6 nm in diameter) were synthesized as we described previously.
Briefly, sodium citrate (10 mL, 34 mM) was quickly added into a refluxing (100C) AgNO3
aqueous solution (500 mL, 1.1 mM) under stirring. The mixture was refluxed and stirred
for 45 min, as the solution color turned from colorless to straw yellow, then opaque and
finally muddy yellow. The heating was stopped and the solution was cooled gradually to
room temperature under stirring. The NP solution was filtered using 0.22-µm filters. All
chemicals, except those indicated, were purchased from Sigma and used as received.
The NPs were immediately washed three times with nanopure DI water (18 M,
Barnstead) using centrifugation (Beckman, JA-14) to remove any residual chemicals
involved in NP synthesis. The washed NPs were resuspended in DI water and then egg
water. The washed NPs were very stable (non-aggregated) in DI water for months and
remained stable in egg water (1.0 mM NaCl, 99.95% Sigma, in DI water) throughout the
duration of the entire experiment (120 h, period of complete embryonic development)
(Figure 22). Concentrations of NPs were calculated, as we described previously.
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Sizes of NPs were characterized using high-resolution transmission electron
microscopy (HR-TEM) (JEOL, JEM-2100F) and dynamic light scattering (DLS) (Nicomp
380ZLS particle sizing system). In this study, the DFOMS is equipped with a dark-field
optical microscope with a dark-field condenser (oil 1.43–1.20, Nikon) and a 100× objective
(Nikon Plan fluor 100× oil, iris, SL. N.A. 0.5–1.3, W.D. 0.20 mm), a CCD camera
(Micromax, Roper Scientific) and a Multispectral Imaging System (Nuance, CRI) was
used to acquire LSPR spectra of single NPs. Stability of NPs in solution and egg water
was followed over time for 120 h using UV-vis spectroscopy, DLS and DFOMS.
Breeding of zebrafish embryos
Wild-type adult zebrafish (Aquatic Ecosystems) and Tg(pax2a:GFP) adult
zebrafish were housed in a stand-alone system (Aquatic Habitats), and they were
maintained and cross-bred, as described previously.44, 113 Briefly, two pairs of mature
female transgenic zebrafish and with one wild type male were placed into a clean 10gallon breeding tank. A light (14 h)–dark (10 h) cycle was used to trigger breed and
fertilization of embryos.

The embryos at the cleavage stage were collected and

transferred into a Petri dish containing egg water. They were well rinsed with egg water
to remove any possible debris prior to imaging and characterization. All experiments
involving embryos and zebrafish were conducted in compliance with IACUC guidelines
(protocol # 15-012).
Treatment and monitoring of zebrafish embryos
Embryos were collected and transferred into a petri dish containing egg water (1.2
mM NaCl), washed twice with egg water to remove the surrounding debris, and placed
into 48-well plates with each well containing one embryo in egg water. 16 embryos were
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tested per concentration, per stage of development; each experiment was repeated 3
times, totaling 48 embryos analyzed per concentration, per stage of development. Each
developmental stage of embryos in the wells was directly imaged by bright-field optical
microscopy using an inverted Zeiss Axiovert microscope equipped with a 4x objective and
a digital color camera.
Study and characterization of biocompatibility and toxicity of NPs
The cleavage-stage embryos in egg water were incubated with a dilution series of
NPs (0, 0.50, 1.00, 2.00 and 5.00 pM). Each experiment was carried out at least 3 times
and the total number of embryos, 48, were studied for each individual concentration to
gain representative statistics.

NP concentrations were calculated as described

previously.44 Embryos in egg water in the absence of NPs and in the presence of
supernatant were placed in two rows of the 48-well plates as control experiments to probe
the effects of possible trace chemicals from NP synthesis. The embryos in the 48-well
plates were incubated at 28.5C, and directly observed at room temperature using an
inverted Zeiss Axiovert microscope equipped with a digital color camera at 24, 48, 72, 96,
and 120 hpf. Using fluorescent microscopy equipped with filters specific for GFP (455 ex
/505 dclp/525 em), expression of pax2a:GFP will be captured using CCD. Positive
embryos were imaged in real time at key developmental time points that are important to
Brain development (i.e. around the somites and otic placode regions at 17 hpf, and areas
designated for midbrain and hindbrain at 21 hpf) using 10x objective and at each
additional imaged time point using 4x objective. Embryos were monitored in real time to
note any significant changes in the expression of the protein biomarkers in the presence
of Ag NPs as well as any abnormal developmental phenotypes that occur from exposure.
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Quantitative heartbeat study of zebrafish upon Ag NPs concentrations
Both treated and control embryos f were analyzed for heart rates. Embryos were
recorded using the Sony camcorder and Coolsnap Ez (Roper Scientific) using 100 frames
with a 50 ms interval delay. The recordings were taken at 24, 48, and 120 hpf. The
movies were then converted and analyzed for manual counting of the hearts contractions.
The heartbeat per minute was then compared graphically to both the normal and
abnormal developed fish at each concentration.
Dose-dependent accumulation of Ag NPs in developing zebrafish embryos
Treatment solution was sampled out at the start of treatment and at the end of
treatment. The solution was then analyzed using UV-Vis Spectroscopy and spectral
analysis was used to calculate the amount (pmole) of Ag NPs remaining in the solution.
This was then used to calculate the uptake amount (pmole) of Ag NPs that was delivered
to the embryo.
Data analysis and statistics
A minimum of 100 Ag NPs was imaged and characterized for each measurement
of their sizes and stability in egg water using HRTEM and DFOMS. For the study of dosedependent effects and qualitative heart rate analysis of NPs on embryonic development,
a total number of 48 embryos were studied for each NP concentration and each control
experiment over 120 hpf with a minimum of 12 embryos studied in each measurement.
Expression data analysis was taken for all positive embryos from each experiment,
totaling a number of 24 embryos per concentration for expression analysis.
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CHAPTER VI
CONCLUSION
In conclusion, as described in chapter II, we utilized zebrafish embryos as our in
vivo model organism to study the toxicity of Ag+ ions. By statistically comparing the
distributions of normal, deformed, and dead embryos upon their exposure to various
concentrations of Ag+ ion, we found that the Ag+ ion caused deformities and death of the
developing embryos in a concentration-dependent manner, where the critical
concentration of the Ag+ ion was 0.20 µM. Exposure of Ag+ ions led to specific types of
defects in development. However, it is far less drastic than the developing embryos were
exposed to Ag NPs. Thus, we can conclude that toxicity of Ag NPs is not due to the
release of its ions, but rather their own unique physicochemical properties. To this notion,
further investigation into mechanisms of toxicity of Ag NPs is needed to truly understand
them. We found that the Ag+ ion highly affected embryonic development of cardiac
formation and function. We found that heart rate highly depends upon Ag+ concentration.
Likewise, we found a large decrease in embryonic heart-rate of those zebrafish that
developed abnormally, which were significantly lower than the controls at every
development stage. We also found that hatching was significantly delayed for embryos
treated at higher concentrations of the Ag+.
In chapter III, we utilized the developing embryos as in vivo model organisms used
in chapter I, and the same dilution series of Ag+ concentrations to study the stagedependent biocompatibility and toxicity effects of Ag+. Specific developmental stages
during embryogenesis were selected.

We observed that the Ag+ resulted in

concentration-dependent toxicity similar to chapter I in all developmental stages. Our
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results describe a range of developmental defects and absolute death following exposure
of developing zebrafish embryos to micromolar concentrations of Ag+ at particular
embryonic development stages. We also observed cardiac malfunction in all treated
stages, where the Ag+ resulted in a significant decrease in heart rate with increasing
concentration.

We did also observe a significant decreased in deformed embryos.

Similar to results described in chapter I, when comparing the sensitivity of these specific
developmental stages to exposure of the Ag+ to those same specific developmental
stages exposed to our Ag NPs, we found the Ag+ did not cause toxicity as severely as
NPs. This finding further suggests that the toxicity of Ag NPs are not caused by its ions,
but its own unique properties. This study offers new insight into the need to further study
the effects of nanomaterials on developmental biology.
In chapters IV and V, the stability of purified Ag NPs (42 nm) in egg media was
comprehensively characterized before using them to study the biocompatibility and
toxicity of Ag NPs on embryonic development. We found that the NPs remained stable
in egg water up to 120 h, the duration of entire embryonic development.
In chapter IV, we examined the effects of Ag NPs upon the development of specific
stages of development and the defects associated with treatment at those specific
developmental stages. The design of this study was used in this dissertation to compare
stage-specific toxicities of Ag+ ion from chapter II to the toxicity of Ag NPs. In this study,
we observed that increasing NPs concentration at all stages of development resulted in
a significant increase in embryonic death and a correlated decrease in survivability of
normal and deformed zebrafish. Many morphological defects were observed in the
developing embryo, including yolk sac edema, abnormal finfold and tail development,
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head and eye abnormalities, and cardiac malformations at each stage of development.
In general, the number of different types of defects and the severity of each varied with
the stage of treatment and increased with increasing dose of NPs demonstrating the
possibility of selectively targeting specific embryonic developmental pathways by altering
the stage of development and dose of NPs for developmental medicinal studies.
Moreover, it was noted that at this particular size of single Ag NPs, cardiac malformation
was significant despite exposure at different developmental time points. Pericardial sac
edemas were one of the most common types of deformity observed throughout all stages.
In that matter, quantitative analysis of cardiac function was found to be significantly
influenced with increasing Ag NPs concentrations. In particular, we saw a stagedependent effect on cardiac malformation, where stages I, II, and IV were highly
influenced by exposure to a higher dose of the Ag NPs (0.20 and 0.50 nM).

The

investigation of biocompatibility of nanomaterials in specific stages of development of
embryos at single NP level can offer new knowledge about the developmental processes
and environment, and provide new insights into the mechanics of the developing embryo
as well as aid in the finding for functional nano-developmental treatments for various
disorders in early development.
In chapter V, we used our purified Ag NPs from chapter IV to study the
effects of Ag NPs on embryonic neurological development. More specific, we exposed
Tg(pax2a:GFP) zebrafish embryos to diluted concentrations of the Ag NPs, studying the
expression of the pax2a gene during treatment using fluorescent microscopy. This design
approach was more practical to study the molecular mechanism of key developmental
biomarkers that regulate brain development in zebrafish. Sublethal concentrations of the
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Ag NPs (0.00, 0.50, 1.00, 2.00, and 5.00 pM) also showed a phenotypical dependent
morphological effect during development. However, we did not observe a significant
decrease in expression of GFP when exposed to Ag NPs. We observed that a higher
dose of the Ag NPs leads to severe deformities. We also demonstrated the effects of Ag
NPs on cardiac response during exposure. We observed that Ag NPs can decrease the
heart rate of both normal and deformed zebrafish. This study also demonstrated dosedependent effects of Ag NPs on eye development, where higher concentrations of the Ag
NP lead to microphthalmia in developing embryos. We also designed an in vivo assay to
study the uptake of Ag NPs in developing embryos. Here, we observed a significant
difference in uptake of those embryos that developed abnormally or who did not survive
during treatment. This study emphasized different in vivo assays that can be explored to
gain more knowledge on neurological development in zebrafish, which can lead to better
design or more biocompatible biosensors to explore therapeutic and molecular assays of
embryogenesis and neurological diseases.
The results of the research mentioned in this dissertation have demonstrated that
zebrafish embryos are powerful in vivo model system to use to study the biocompatibility
and toxicity of metal ions and nanomaterials. This opens up the possibility of using this
system as a standard assay to screen many different types of multi-functional NPs,
including protein-specific nanomaterials that could potentially be used for targeted
therapeutic applications. There is the possibility of using NPs in vivo environments as
effective drug delivery vehicles by attaching desired drug molecules to the surface of NPs.
For this reason, it is very important to collect preliminary data on how NPs influence
molecular mechanisms and function of key developmental biomarkers during developing
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and if these nanomaterials will be toxic to living cells. To conclude, the chapters included
in this dissertation have shown conclusively the versatile nature of using zebrafish
embryos as an in vivo assay to study the effects of silver ions and silver nanoparticles
during embryonic development.
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